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INTRODUCTION 
1.1. Datura innoxia 
Datura innoxia, a member of the family Solanaceae, is native to North America. The 
plant has been found to contain a number of tropane alkaloids. The flowers and seeds of 
the plant are used to treat skin eruptions, colds and nervous disorders [1-2]. It was mixed 
with  cannabis in wine to use as a narcotic for surgical procedures  in ancient times 
[3].Preliminary screening of the solvent extracts in acetylcholine esterase (AChE) 
inhibition assay and further purification of the active extract yielded scopolamine (1), a 
tropane alkaloid. 
The EIMS spectra of tropane alkaloids is characterized by the presence of an even 
number base peak at  m/z 94.0  due to troplium ion. The 1HNMR of tropane alkaloids 
showed characteristic peaks appears singlet at   δ2.8 due to methyl group and a multiplet 
signal at δ 3.8 attached with the N atom in the tropine ring [3-4].    
1.2 Citrus sinensis 
Citrus sinensis is a member of family Rutaceae native to Asia, which is cultivated all  
over the world  [5-6]. The extract of leaves has been used in folk medicine to treat 
neurological disorders  and to  facilitate the digestion of food [7]. It contains a host of 
active phytochemicals, that contribute to health. In fact, many classes of compounds have 
been isolated from C. sinensis such as glycosides, ruteoside, caffeine, hydroxyl proline, 
flavonoids and triterpene linomin [8-11]. It is commonly accepted that consumption of 
certain foods can prevent cancer [12]. The  flavonoids including hesperidin, narirutin, 
naringin, neohesperidin, eriocitrin, neoeriocitrin, rutin, diosmin, neoponcirin, and 
nobiletin in citrus fruits, are among the most prominent cancer-preventing agents[13-16]. 
Hesperetin (2), and hesperidin (3) were isolated from the plant during the study.  
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1.3  Acacia catechu 
Acacia catechu belongs to the family Fabaceae. The extract of A. catechu, is used to treat 
sore throats and diarrhea in folk medicine. The  extracts  of  the plant  have  been    used  
in  many   traditional  medicines  and pharmaceutical   products, especially in Asia for a 
variety of  purposes,  including anti-inflammatory,  antiviral, anti bacterial, anti cancer 
and cardiovascular applications [17]. It has been reported in the literature that  phenolic  
compounds are the major secondary metabolites isolated from  A. catechu [17]. Bioassau-
guided fractionation of the plant extracts resulted in the purification of gallic acid (4), 
tannic acid (5) and catechin (6) from the plant extracts.  
Spectral Properties of Flavonoids 
Flavonoids show UV absorption maxima in the range of 330-386nm (band I) and 240-
280 nm (band II) [18]. Band I is associated with the presence of a B-ring cinnamoyl 
system. Band II absorption is due to an A-ring benzoyl system. FABMS spectra of 
flavonoid glycosides have typical pattern, which depends mainly on the number or nature 
of the bound saccharides and their C- or O-glycosidic linkages[19]. The loss of fragments 
with well-defined mass from the pseudomolecular ion can provide precise information 
about the linked saccharides, such as in the FAB positive spectrum of hesperidin the 
fragment at m/z 463 was generated by the loss of one sugar unit (rhamnose) from the 
pseudomolecular ion [M–H]- (m/z 609). Subsequent loss of a second sugar unit (glucose), 
generates the fragment ion at m/z 301, which can be easily assigned to the aglycone [20]. 
1.4 Melia azedarach 
M. azedarach  has been extensively used in Ayurveda, Unani and homoepathic medicine, 
and has  become a  symbol of modern medicine [21]. The most important bioactive 
compound is azadirachtin [22]. The inner bark contains a resinous alkaloidal substance 
and is used as an anthelmintic. Various studies indicated the analgesic, anticancer, 
antiviral, antimalarial, antifeedent and antifertility activity of this plant [23]. Vanillin (7) 
was isolated from the ethyl acetate extract of the plant. 
  
 13 
1.5 Impatiens bicolor 
Impatiens bicolor Royle (Balsaminaceae), locally called  bantil is an annual herb, 45-60 
cm tall. I. bicolor is an endangered species and distributed in northern areas in Murree,  
Nathia Gali,  Swat  and  Miran Jani  in  Pakistan. It has been used locally as diuretic and 
tonic due to its cooling effect [24]. The plants of genus Impatiens are rich in organic 
acids, anthraquinones and flavonoids [25]. Bioassay- guided purification of the ethyl 
acetate extract of this plant yielded ferulic acid (8). 
1.6 Cinnamomum zeylanicum 
Cinnamomum zeylanicum Blume (Lauraceae), has many biological properties such as 
analgesic, antiseptic, antispasmodic, aphrodisiac, astringent, carminative, haemostatic, 
insecticidal and parasiticide.  Barks from branches, without the epidermis and subereous 
layer, is marketed as the commercial cinnamon, which has been used in perfumery, 
culinary and native medicine fields [26-27].  Previous research has revealed interesting 
antimicrobial effect in the essential oil C. zeylanicum [28]. Cinnamic acid (9) was 
isolated from the most active extract of C. zeylanicum .  
Characteristics of Phenolic acids 
Phenolic compounds contain a wide range of structures i.e. from simple structure 
containing a single hydroxylated aromatic ring to the highly complex polymeric 
substances [29-30]. Hydroxybenzoic acids have a general structure of C6-C1 derived 
from benzoic acid. Variations in the structures of individual hydroxybenzoic acids lie in 
the hydroxylation and O-methylation of the aromatic ring. Four phenolic acids; p-
hydroxybenzoic, vanillic, syringic, protocatechuic acid, and four hydroxycinnamic acids; 
p-coumaric, caffeic, ferulic and sinapic acids are most abundant in plants [31]. The main 
mass fragments present in the EIMS of the pehonlic acids are M+-45 (-COOH), M+-17 (-
OH). 1H NMR showed a phenyl ring system (7.97 ppm [2H, d], 7.0 ppm [2H, d] and 8.19 
ppm [2H, dd]), three aromatic or olefinic protons [8.85 (s), 6.66 (d), and 6.86 (d) ppm]. 
Phenolic acids are well known for their medicinal properties. The biological activities of 
phenolic acids are summarized in Table 1.1. 
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Table 1.1 Biological activities of phenolic acids 
Sr. 
No. 
Phenolic Acid Activities Reference  
1 Gallic acid Anticancer, anti-inflammatory, xanthine oxidase, 
antimutagenic and antioxidant 
[32, 33, 34] 
 
2 Ferulic acid Antioxidant, acetylcholine esterase, antifungal, anti-
inflammatory, xanthine oxidase and glucosidase 
[35-37] 
 
3 Caffeic acid Anticarcinogenic, anti-inflammatory, antimutagenic, 
xanthine oxidase, lipoxygenase, glucosidase and 
antioxidant 
[38-40] 
 
4 Cinnamic acid  Antianthelmic and antifungal [41] 
5 Coumaric acid Xanthine oxidase, anti-inflammatory and 
antileukemic 
[42] 
6 Chlorogenic 
acid 
Xanthine oxidase, antidiabetic, anticarcinogenic, 
antimutagenic and antioxidant 
[32, 43] 
7 Rosmarinic 
acid 
Antioxidant, anti-inflammatory, antiphlogistic, 
antimutagenic, antibacterial, antiviral and  xanthine 
oxidase 
[32] 
 
1.7 Artemisia vulgaris 
Artemisia vulgaris L. grows  in arid and semi-arid areas of Baluchistan, North-West 
Frontier Province, Northern Punjab and Kashmir [44].  The aromatic leaves of Artemisia 
vulgaris is important with respect to their use in medicine and some are being used for 
flavoring. It has also been identified that different parts of A. vulgaris can be used as 
antibacterial, anti-inflammatory, antiseptic, diaphoretic and stimulatory agents [45]. 
Recently, it has been reported that the aqueous extract of A. vulgaris is a potential source 
of natural antioxidant[46]. The identified active components of A. vulgaris include 
flavonoids, coumarins, sesquiterpene lactones, volatile oils, inulin, and traces of 
alkaloids. The chief compounds of volatile oil include camphor, camphene, a-thujone, 
germacrene 1,8-cineole, and β-caryophyllene [47]. Artemisinin (11) was isolated from 
the plant during bioassay-guided purification of ethyl acetate extract. 
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1.8 Enzymes Inhibition 
The process in which a molecule binds with an enzyme to decrease its activity is called 
enzyme inhibition. The activity of many enzymes can be inhibited by the binding of 
specific small molecules and ions other than the substrate. Inhibition of enzyme activity 
serves as a major control mechanism in biological systems, such as allosteric enzymes. In 
addition, many drugs and toxic agents (pesticides, nerve gases, etc.) act by inhibiting the 
enzymes. Inhibition of the enzymes by particular chemicals, can be used to study the 
mechanism of enzyme action, for example specific inhibitors can often be used to 
identify residues critical for catalysis. Depending upon their mode of action, inhibitors 
have been classified into three major categories; competitive, non-competitive, and un-
competitive [48]. 
1.8.1 Competitive inhibitors 
In competitive inhibition, an enzyme binds with the substrate (ES complex) or inhibitor 
(EI) but not with (ES) to form (ESI). The competitive inhibitor resembles structurally 
with the substrate and binds to the active site of the enzyme. The substrate is thereby 
prevented from binding to the same active site. A competitive inhibitor lowers the rate of 
catalysis by reducing the proportion of enzyme molecules bound to a substrate. At any 
given inhibitor concentration, competitive inhibition can be relieved by increasing the 
substrate concentration. Under these conditions, the substrate “outcompetes” the inhibitor 
for the active site. The interaction of the competitive inhibitor with the enzyme is 
presented in Fig-1.1. 
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E + S
Ks kp
ES E + P
+
I 
Ki
EI  
Fig. 1.1 Classical competitive-type of inhibition 
1.8.2 Non-Competitive inhibitors  
In non-competitive inhibition, which is also reversible, the inhibitor and substrate can 
bind simultaneously to an enzyme molecule at different binding sites. A non-competitive 
inhibitor acts by decreasing the turnover number rather than by diminishing the 
proportion of enzyme molecules that are bound to substrate. Non-competitive inhibition, 
in contrast to competitive inhibition, cannot be overcomed by increasing the substrate 
concentration. Fig-1.2 shows the interaction of the non-competitive inhibitor with the 
enzyme.  
   
E + S
Ks kp
ES E + P
+
I 
ESI
Ki
+
I 
EI + S
Ki
Ks
 
Fig-1.2 Classical non-competitive type of inhibition. 
In Fig-1.2, [I] and [S] bind randomly and independently at the different sites of the 
enzyme. It indicates that inhibition depends only on the concentration of [I] and 
dissociation constant [Ki]  [49]. 
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1.8.3 Un-competitive inhibitors  
A classical un-competitive inhibitor is a compound that binds reversibly to the enzyme-
substrate complex (ES), yielding an (ESI) complex.  
E + S
Ks kp
ES E + P
+
I 
Ki
ESI  
Fig-1.3 Classical un-competitive type of inhibition. 
Classical un-competitive inhibition is presented in Fig. 1.3. The equilibria shows that at 
any [I], an infinitely high substrate concentration will not drive the entire enzyme to the 
(ES) form; some nonproductive (ESI) complex will always be present. This figure also 
shows that an un-competitive inhibitor decreases the Vmax and Km to the same extent. 
1.8.4 Acetylcholinesterase 
Structure and mechanism  
AChE consists of a complex protein of the α/ β hydrolase fold type with  overall ellipsoid 
shape containing at deep groove, usually called the gorge, which is about 20 A° deep. 
Hydrolysis of acetylchline (ACh) appears to take place at the bottom of the gorge. 
Although,  hydrolysis process takes place in the base of the gorge, initial binding of ACh 
is thought to occur at its outer rim in a region called the “peripheral site”. At the bottom 
of the gorge, where the actual hydrolysis occurs, there are four main subsites, these being 
the “esteratic site”, the “oxyanion hole”, the “anionic subsite” and the “acyl pocket” (Fig. 
1.4).  
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The substrate enters the enzyme gorge and the product is released in conjunction with 
defined conformational changes. The esteratic site contains the catalytic machinery of the 
enzyme, which is dependent on a catalytic triad of Ser200-His440-Glu327 [50]. 
Cholinesterases use this triad to enhance the nucleophilicity of the catalytic serine, since 
the strong hydrogen bond between His and Ser improves the ability of Ser to mount a 
nucleophilic attack on the substrate, while Glu stabilizes the histidinium cation of the 
transition state (Figure-1.5) [51]. 
The “oxyanion hole” (OH) consists of Gly118, Gly119 and Ala201. These three peptide 
residues contain hydrogen bond donors and they stabilize the tetrahedral intermediate of 
Ach, which is formed during the catalytic process [52]. 
The “anionic subsite” (choline-binding subsite or hydrophobic subsite) is largely 
comprised of aromatic residues and contains Trp84, Phe330 and Glu199, which are 
believed to bind to quaternary ammonium ligands by π-cation interaction . The positive 
charge of the quaternary ammonium group of ACh can form a stable interaction with the 
electron-rich π systems of aromatic rings [53].  
The “acyl pocket” (acyl binding pocket or acyl-binding pocket) consists of Phe288 and 
Phe290, which are believed to play a role in limiting the dimension of substrates, which 
are able to enter the active site [51]. 
 19 
 
 
Fig. 1.4 The binding regions of the AChE gorge. 
.  
 
AChE is one of the fastest hydrolytic enzymes. It has about 103 fold and 1013 fold greater 
activity than serine proteases and BChE respectively, in the spontaneous hydrolysis of 
ACh at the same temperature and pH [54]. Due to the high turnover of the enzyme and 
the strong electrostatic dipole caused by the asymmetric charge distribution, it is unlikely 
that the choline produced by hydrolysis leaves the active site through the same path by 
which the substrate entered. For this reason the “back door” mechanism has been 
proposed in order to account for these properties. It has been proposed, based on 
molecular dynamics and site-directed mutagenesis that the process occurs through the 
opening of the bottom of the AChE gorge to provide a channel through which the 
products can pass, so enabling a part flow of substrate through the enzyme active site 
[55].  
 20 
 
Fig. 1.5 The release of ACh hydrolysis products from the bottom of the gorge.  
1.8.5 Importance of enzyme inhibition  
Enzyme inhibition is an important area of pharmaceutical research, and studies in 
this field have already been resulted in the discovery of a wide variety of drugs, useful in 
a number of diseases. Specific inhibitors interact with enzymes and block their activity 
towards their corresponding physiological substrates. The importance of enzyme 
inhibitors as drugs is enormous, since these molecules have been used for treating a large 
number of physiological conditions. For example, urease inhibition has been regarded as 
an important approach towards new antiulcer drugs. Similarly, DNA topoisomerases can 
ensure that as DNA divides it does not come under too much torsional stress. Agents that 
inhibit this mechanism can act against rapidly dividing cancer cells. Angiotensin-
converting enzyme (ACE) inhibitors are used in the treatment of high blood pressure. 
They may be used alone or in combination with other medicines for controlling 
hypertension. They work by preventing angiotensin I in the blood, from being converted 
into a substance that increases salt and water retention in the body. AChE inhibitors can 
also make blood vessels relax, which lower blood pressure and allows more oxygen-rich 
blood to reach the heart. Therefore, enzyme inhibitors can be used to treat a number of 
complex disorders such as cancer, ulcer, high blood pressure, inflammation, 
cardiovascular disorder and infectious diseases [56]. 
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Aims and Objectives 
Acetylcholinesterase is the major enzyme which plays a vital role to control the nerve 
impulses in the human body. As only few compounds are available as a medicine for the 
treatment in the market, therefore, the main objective of the present study was to purify 
and identify acetylcholinesterase inhibitors from local  medicinal plants and to study their  
structure-activity relationship.  
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LITERATURE REVIEW 
 
In medicine acetylcholine esterase enzyme inhibitors (AChEIs) are employed mostly for 
correcting the effects of insufficient levels of ACh. The oldest application in this respect 
is in ophthalmology for the treatment of glaucoma. Physostigmine was formerly used in 
this way but has now been largely replaced by cholinomimetics, such as pilocarpine.  
Until recently, another major use for naturally occurring AChEIs was for the treatment of 
myasthenia gravis, where muscle weakness occurs due to insufficient ACh at the 
neuromuscular junction. The distribution of physostigmine itself in the body is too 
general and was not sufficiently restricted to the peripheral nervous system. Synthetic 
analogues of physostigmine have therefore been made and the two most in therapeutic 
use are neostigmine and pyridostigmine, which include a quaternary nitrogen, ensuring a 
permanent charge. This result in any detectable amounts affecting only the peripheral 
nervous system, since crossing of the blood-brain barrier is prevented.  
The advent of the hypothesis connecting Alzheimer’s disease and low levels of ACh in 
the brain [57] provided a new application for AChEIs, since they could increase the ACh 
levels. In addition, AChE has been postulated to accelerate the deposition of extracellular 
plaques of β-amyloid which are characteristic of the abnormal histology of the forebrain 
of patients with Alzheimer’s disease [58]. Rivastigmine  is used clinically and is an 
analogue of physostigmine which has been developed to cross the blood-brain barrier and 
so act mainly in the CNS. The alkaloid galantamine , was also licensed for use in early 
stages of Alzheimer’s disease in 2001, and is now widely employed in this respect, 
especially since it appears to have nicotinergic effects which increase its effectiveness in 
treating AD [59]. 
Cholinesterase inhibitors have also been used as antidotes to toxins such as the tropane 
alkaloid atropine, which are competitive inhibitors of ACh. Intoxication may occur 
through ingestion of plant material containing these compounds, or from overdosing of 
medicinal products which contain them as the active ingredients. 
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A major use of AChEIs is in agriculture where they are used for the control of insects and 
some other arthropod pests. This use extends into pharmacy since some AChEIs are used 
as insecticides for treating infections of headlice. Insecticidal activity is based on the 
overstimulation of the cholinergic system in the insect. The original AChEIs used were 
derived from compounds developed from organophosphorus war gas agents which bind 
irreversibly to AChE [60].  
A number of studies have been conducted in order to investigate the interaction between 
inhibitors and AChE. These include X-ray diffraction of the crystal complex between 
AChE and inhibitors as well as site-directed mutagenesis [61]. Inhibitors can be divided 
between those that bind to the active site at the bottom of the gorge and those that bind to 
the peripheral anionic site (PAS). As far as the alkaloidal inhibitors are concerned, 
binding takes place at the active site at the bottom of the gorge and the important features 
of an inhibitor appear to be a positively-charged nitrogen, which binds to the oxyanion 
hole area, especially the Trp84, and a region, separated by a lipophilic area from the 
positive charge, which can form hydrogen bonds with the serine200 residue and others 
such as His440 [62]. 
Table 2.1 Natural Products as AChE inhibitors 
Sr. 
No. 
Source Compounds IC50 /μM 
against 
AChE 
 
Ref. 
01 Narcissus species sanguinine 0.01 63 
02 11-hydroxygalantamine 1.61 63 
03 Huperzia serrata huperzine A 0.023 64 
04 Corydalis speciosa berberine 0.23 65 
05 Sarcococca hookeriana hookerianamide-F 1.5 66 
06 sarcovagine-D 2.2 66 
07 Prosopis juliflora juliflorine 0.42 67 
08  xanthotoxin 0.58 68 
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09 A. acutiloba isopimpinellin 0.32 68 
10 Caragana chamlague (1)-α-viniferin 1.0 69 
11 
Aspergillus terreus 
 
isoterreulactone A 2.5 70 
12 terreulactone A 0.23 70 
13 terreulactone B 0.09 70 
14 terreulactone C 0.06 70 
15 terreulactone D 0.42 70 
16 Aspergillus terreus 
Penicillium sp. FO-4259 
 
arisugacin A 1.0 71 
17 arisugacin B 25.8 71 
18 
Aspergillus terreus 
 
arisugacin C 2.5 71 
19 arisugacin D 3.5 71 
20 territrem A 7.6 71 
21 Aspergillus terreus 
Penicillium sp. FO-4259 
 
territrem B 7.6 71,72 
22 territrem C 6.8 71,72 
 
Alkaloids as AChE inhibitors  
Four indole alkaloids have been isolated from Desmodium pulchellum and D. gangeticum 
(Papilionaceae) [73]. These all displayed AChE inhibitory effects with legucin A being 
the most active with IC50 =27 μM. A different type of indole alkaloid, 
dehydroevodiamine, from the unripe fruit of Evodia rutaecarpa inhibited AChE in vitro 
(IC50 37.8 μM), and reversed scopolamine-induced memory impairment in rats [74]. 
The indole alkaloids coronaridine, voacangine, voacangine hydroxyindolenine  and 
rupicoline from the stalks of Tabernaemontana australis (Apocynaceae) were shown to 
inhibit AChE. This was revealed by the TLC assay using the modified Ellman’s method, 
but no values to compare activities were reported [75]. 
Nine indole alkaloids from Chimarrhis turbinate (Rubiaceae) bark and leaves were 
screened for antiAChE activity, and two of these compounds, turbinatine (IC50 =0.1 μM) 
and desoxycordifoline  (IC50 =1.0 μM) also showed moderate inhibitory activity [76]. 
The toxicity of some members of the Amaryllidaceae had been known for some time and 
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the alkaloids present were found to be largely responsible. Galantamine (sometimes 
referred to as galanthamine) was first isolated from Galanthus spp., the snowdrop, by 
Bulgarian scientists in the mid twentieth century [77]. It displays fairly storage in vitro 
AChE inhibitory activity with IC50 of 1.07 μM [78].  
A more recent study on alkaloids from Corydalis speciosa has confirmed that berberine is 
very active [79]. The strong activity of compounds indicates that a quaternary nitrogen is 
necessary for strong activity in alkaloids possessing the benzylisoquinoline skeleton. The 
in vitro activity of compound has been shown to be translated into in vivo effects since it 
improved scopolamine-induced amnesia in rats [80]. Five bisbenzylisoquinoline alkaloids 
obtained from Cocculus pendulus (Menispermaceae) have recently been reported to 
inhibit AChE [81]. 
Tubocurarine is obtained from Chondodendron tomentosum (Menispermaceae) and 
classical pharmacology ascribes its action to competition with ACh at nicotine receptors. 
However, recent studies have shown that it inhibits AChE to some extent [82]. 
A prominent family in this respect is  Solanaceae and the toxicity of the green parts of 
members of Solanum and related spp. can be largely ascribed to the presence of these 
compounds. α-solanine and α-chaconine  have been shown to have a moderately strong 
AChEI effect [83]. 
 Four novel alkaloids from S. saligna had much less activity with saracocine  being the 
most potent with IC50 =20 mM [84]. These alkaloids were also shown to inhibit 
butrylcholine esterase (BChE) with a dependency on concentration in vitro and were 
more selective for BChE than AChE [85]. Some other pregnane-type alkaloids from S. 
saligna have an antiAChE activity [86]. Sarcovagenine-C  has also been isolated from the 
whole plant of Sarcococca hookeriana (Buxaceae), along with several other steroidal 
alkaloids. The most potent inhibitors of AChE were  hookerianamide-F  and sarcovagine-
D  (IC50 1.6 μM, 1.5 μM, 2.2 μM, respectively); structural features of these compounds 
that were related to activity were the tigloyl-amino group at position C-3 and the carbonyl 
moiety in ring A [86]. Buxamines B and C , alkaloids isolated from Buxus papillosa and 
B. hyrcana (Buxaceae) inhibit AChE concentration-dependently and non-competitively 
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(IC50 74 μM and 7.5 μM, respectively) [87].  
The piperidien alkaloid juliflorine has been isolated from the leaves of Prosopis juliflora 
(Papilionaceae) and non-competitively inhibits both AChE (IC50 =0.42 μM) and BChE 
(IC50 =0.12 μM) concentration-dependently [88].  
Species of Aconitum, Delphinium and related genera of family Ranculaceae have long 
been known to contain complex diterpene alkaloids such as aconitine, some of which are 
very toxic. These are known to affect Na+ channels but aconitine derivatives, isolated 
from Aconitum falconieri, are reported to give a weak inhibition of AChE with IC50 
values 293 and 278 μM respectively [89].  
The tropane alkaloid cocaine is reported to inhibit BChE more than AChE [90]. Two 
acridones quinolactacin A1 and A2 were isolated from the fungus Penicillium citrinum ( 
Trichocomaceae) [91-92]. Regarding AChE inhibiton activity of alkaloids ,  hypothesis 
was developed for the binding site on the enzyme, which involved the interaction of the 
positively-charged ‘N’ with an anionic site in the cleft as an integral and important 
feature of any inhibitory mechanism. It was, therefore, somewhat surprising when AChE 
inhibition by non-alkaloidal compounds began to be reported about twenty years ago, and 
it was these findings which have stimulated the proposals that other binding sites are 
involved in inhibitory processes which do not necessitate an actual or potential 
positively-charged moiety in the inhibitor. The two major types of natural products found 
in flowering plants which have been found as inhibitors are the terpenoids and a variety 
of compounds biosynthesized via the shikimaic  pathway.  
Phenolic compounds as AChE inhibitors  
The shikimic acid pathway is a manor route for the production of a large number of 
different types of compound in flowering plants. Compounds produced are usually 
phenolic in nature and have a skeleton derived from just one phenylpropanoid unit alone, 
two units combined together or one or more phenyl-propanoid units combined with 
fragments arising from other metabolic pathways. Compounds inhibiting AChE have 
been reported from all these three types. The coumarin scopoletin was isolated as the 
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more active AChEI component (IC50 = 79 μM) of the methanolic extract of Vaccinium 
oldhami (Ericaceae) [93].  
Flavonoids as AChE inhibitors  
N-p-Coumaryltyramine, an unusual combination of phenylpropanoid and amino acid, was 
isolated from twigs of Celtis chinensis (Ulmaceae) and had a weak AChEI effect (IC50 
=122 μM) [94]. Studies on a variety of compounds including chalcones, flavonoids, 
lignans, phenylpropanoids, xanthones and a few terpenoids showed that six xanthones  
were the most active compounds together with a flavonoid  [95]. The biological activity 
of flavonoids has attracted much interest in the last twenty years and a few compounds of 
this class have been shown to have AChEI effect. The flavonone naringenin from Citrus 
junos (Rutaceae) ameliorated scopolamine-induced amnesia in mice, which may be 
related to an antiAChE effect, since naringenin was shown to dose-dependently inhibit 
AChE in vitro [96]. Another flavonone, hispidone, isolated from Onosma hispida 
(Boraginaceae) was moderately active (IC50 =11.6 μM) [97]. 
The activity of the flavonoid, noted above, was about 15 times weaker than galantamine 
[99]. Two polyphenolic stibene oligomers named (1)-α-viniferin and kobophenol A were 
isolated from the roots of Caragana chamlague (Papilionaceae) [100]. Kobophenol A  
was by far the more potent (IC50 =1.0 μM against human serum AChE) whereas the 
compound was two orders of magnitude weaker (IC50 115.8 μM). Some recent studies 
show that polyphenols from green tea dose-dependently inhibit AChE [101]. However, 
studies investigating structure-activity relationships for these compounds are lacking. 
Terpenoids   as AChE inhibitors  
A group of isocoumarin meroterpenoids isolated from Aspergillus terreus and 
Penicillium species, has been found to contain some potent AChE inhibitors. 
Isoterreulactone A and terreulactones A-D, meroterpenoids isolated from Aspergillus 
terreus [102], inhibited AChE in a dose-dependent manner in vitro and were more 
selective for AChE compared to BChE[103]. Arisugacins A  and B  are selective 
inhibitors of AChE (non- selective for BChE) and have been shown to be 200-fold more 
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potent than tacrine in vitro. Several other arisugacins  were isolated and tested although 
not all showed activity [104]. Another group of fungal metabolites obtained from 
Aspergillus terreus were the territrems A-C  [105].  
Since the anti AChE arisugacins lack nitrogen, their mechanism for interaction with 
AChE is likely to differ from that of compounds containing quaternary nitrogen such as 
ACh. The suggested mechanism for binding to AChE is an electron-donating-electron-
withdrawing interaction; the donation being from the electron density of the dimethoxy 
group, coupled with electron-withdrawing of the 2-pyrone ring, a moiety which is 
considered crucial for anti AChE potency [106]. Another group of meroterpenoids have 
been obtained from liquid cultures of the phytopathogenic fungus Nectria galligena 
(Hypocreaceae) and assessed for anti AChE activity in vitro. The meso terpenoids 
collectochlorin B, colletorin B, ilicicolins C, E, and F, as well the phytotoxin α,β-
dehydrocurvularin, showed moderate inhibitory activity against AChE [107]. 
 
Miscellaneous compounds as AChE inhibitors  
Compounds from Buddleja crispa (Buddlejaceae) identified as nonyl benzoate and hexyl 
p-hydroxycinnamate weakly inhibited both AChE and BChE [108]. Ceramides, 
tanacetamides A and B, isolated from the whole plants of Tanacetum artemisioides 
(Asteraceae) are reported to inhibit AChE in vitro (IC50 =67.1 μM and 74.1 μM 
respectively) [109]. The polyketide-derived aflatoxins are fungal metabolites from 
Aspergillus flavus which are well-known because of their toxicity. Part of the basis for 
their severe toxic effects is a strong cholinergic stimulation [110]. Aflatoxin B1 has been 
shown to non-competitively inhibit mouse brain AChE, and its G1 and G4 molecular 
isoforms in particular, in a dose-dependent manner [111]. Another aromatic compound 
14-(2΄,3΄,5΄-trihydroxyphenyl) tetradecan-2-ol obtained from a species of the fungal 
genus Chrysosporium showed weak activity (IC50 =231 μM)  [112]. Investigations on the 
constituents of an unknown Xylaria species of fungus resulted in the isolation of a series 
of unique compounds, the xyloketals, of which xyloketal A  showed a strong inhibitory 
effect against AChE (IC50 =1.5 μM) [113]. 
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Three other unusual compounds, ACh containing a phosphorus atom, have been isolated 
from Streptomyces species as part of a search for novel insecticides against the housefly. 
Compounds, known only as CGA 134735 181 and CGA 134735 182 were isolated from 
S. antibioticus [114] and were strong inhibitors (IC50 =0.57 μM and 0.09 μM 
respectivley) against bovine erythrocyte AChE. Another phosphor-compound, 
cyclophostin was obtained from S. lavendulae [115] and displayed very strong AChE 
inhibition (IC50 =0.0013 μM) against human erythrocyte AChE.  
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EXPERIMENTAL WORK 
 
General Experimental Conditions 
The UV spectra were obtained in MeOH on a CECIL-7200 instrument, while the IR 
spectra (KBr) were determined on a MIDAC, M-2000, USA spectrometer. The 1H NMR 
spectra were recorded in CDCl3 on Bruker AM-400 NMR spectrometers at 400 MHz . 
The 13C NMR spectra were recorded at 100 MHz in CDCl3 using TMS as an internal 
standard. EIMS were recorded on a Varian MAT 312 double focusing mass spectrometer 
operating at 70 eV. The FAB MS spectra were recorded on a JEOL JMS-HX110 mass 
spectrometer. The purities of the samples were checked by TLC on silica gel precoated 
plates (Merck). All the solvents used in the study were of Panearc analytical grade, while 
chemicals used in the enzyme assay were of Sigma-Aldrich analytical grades.  Standard 
deviation method was used in the tabulation of results, while GraFit software applied for 
the study of enzyme kinetics. 
3.1 Datura innoxia 
3.1.1 Collection and identification 
 Whole plant of Datura innoxia (9.14 kg) was collected from Johar Town Lahore 
Pakistan and indentified at the Department of Botany, GC University Lahore, where a 
voucher specimen (GCU-BOT.24) was submitted.  
3.1.2 Bioassay guided fractionation 
The air dried plant material was grinded and soaked in ethyl alcohol (12 L) at room 
temperature for two weeks. The extract was concentrated under vacuum at room 
temperature using rotary evaporator. The crude gum (354 g) thus obtained was dissolved 
in distilled water and defatted with n-hexane. The defatted aqueous extract was further 
extracted with chloroform at pH 7.0 , pH 3.0  and pH 9.0. All the extracts were screened 
against  AChE activity at a concentration of 200μg/mL using Ellman’s method [116]. On 
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the basis of AChE inhibition activity of the extracts, the chloroform extract obtained at 
pH 9.0 was subjected to silica gel column chromatography. Mixtures of n-hexane-
chloroform, chloroform-ethyl acetate and ethyl acetate- methanol were used as eluents. 
The fractions showed similar behavior on tlc plate were pooled and screened against 
AChE.  
 
Table 3.1  AChE inhibition activity of the extracts of Datura innoxia 
S. No.  Extract (200µg/mL) AChE inhibition (%) 
01  
chloroform   
  
pH: 7.0 3.2±0.29 
02 pH: 3.0 07.3±0.11 
03 pH: 9.0 35.9±0.18 
04 n-butanol  12.9±0.31 
 
  
Table 3.2 AChE inhibition activity of the column fractions of chloroform 
extract (pH 9.0) of D. innoxia 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 3.1±0.15 
2 Chloroform  12.1±0.27 
3 Chloroform-ethyl acetate (50:50) 49.4±0.12 
4 Chloroform-ethyl acetate (10:90) 27.2±0.19 
3.1.3 Isolation of scopolamine (1) 
The extract obtained at pH 9.0 (table 3.1), showed highest AChE activity, was further 
subjected to column chromatography using silica packed column. The fractions obtained 
in chloroform-ethyl acetate (50:50) were pooled, dried and rechromatographed which 
yielded 18 mg scopolamine (1) as a brown gum (0.001% yield).  
 
  
 32 
Spectral Data 
UV (MeOH) λmax: 235 nm 
IR (KBr , cm-1) υ max: 3419 (OH), 2936(CH), 1726 (C-O), 1033 (C-N). 
EIMS m/z (rel. int., %): 303.1 (M+, 5.49), 154.1 (16.51), 138.1 (73.56), 108.1 (50.72), 
94.1 (100.0), 57.0 (15.70). 
1H-NMR (CDCl3, 500 MHz): δ 7.35 (3H, m, H-3,4,5 ), δ 7.0 (2H, m,H-2,6) , δ 5.0 
(1H,m,H-1'), δ 4.1 (1H, q,H-9[b]), δ 3.9 (4H, m, H-3',4',5',6'),  δ 3.8 (2H,m,H-7,9 [a]), δ 
2.8 (3H,s,H-8'), δ 2.0 (2H, m,H-2',7'). 
13C-NMR  (CDCl3, 125 MHz): δ 172.5 (C-8), δ 137.1 (C-1), δ 130.0 (C-2), δ 129.6 (C-6), 
δ 129.4 (C-5), δ 129.2 (C-3), δ 127.2 (C-4), δ 64.5(C-9,1'), δ 58.4 (C-4'), δ 58.1 (C-5'), δ 
55.9 (C-3'), δ 55.7(C-6'), δ 53.8 (C-7), δ 31.1 (C-8'), δ 29.4 (C-7'), δ 29.1 (C-2'). 
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Datura innoxia
(1) Extracted with ethanol 
(2) Evaporated
Crude extract*
Dissolved in water
Extraced with n-hexane 
Insoluble
Aqueous layer
Aqueous layer
Aqueous layer
Extraced with chloroform
                 
(2) Extraced with chloroform 
(1) Adjusted pH 3-4 with 
25 % glacial acetic acid
(1) Adjusted pH 8-9 with 25 
%  liq.ammonia
(2) Extraced with chloroform 
Aqueous layer
Soluble
Organic layer dried 
over anhydrous 
Na
2
SO
4
,filtered and 
evaporated*
Organic layer dried 
over anhydrous 
Na
2
SO
4
,filtered and 
evaporated*
Organic layer dried 
over anhydrous 
Na
2
SO
4
,filtered and 
evaporated*
Organic layer 
evaporated*
* Subjected to AChE inhibition assay 
Scopolamine (1)
18 mg
Preprative TLC
ethyl acetate:methanol
                90:10
 
Scheme 3.1 extraction scheme of Scopolamine (1) from Datura innoxia 
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3.2 Citrus sinensis 
3.2.1 Collection and identification 
The fruit of C. sinensis (2.28 kg) was collected from Lahore region Pakistan and the plant 
was identified at the Department of Botany, GC University Lahore, where a voucher 
specimen (GCU-BOT-146) was submitted. The material was air dried under shade and 
grinded. 
3.2.2 Extraction and bioassay- guided fractionation 
The fruit peels of C. sinensis were air dried grinded and extracted successively with n-
hexane, chloroform, ethyl acetate and methanol (2 L each) using soxhlet apparatus 
(scheme 3.2). All the extracts were concentrated under vacuum at room temperature and 
screened for AChE activity. Each extract thus obtained was screened against AChE using 
Ellman’s method at a conc. of 200μg/mL (table 3.3). The ethyl acetate and methanol 
extracts showed significant activity and therefore, proceeded further for purification. 
 
Table 3.3 AChE inhibition activity of the crude extracts of Citrus sinensis 
 
S. No.  Extract (200µg/mL)  AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 1.3± 0.24 
03 Ethyl acetate 13.2± 0.48 
04 Methanol 19.4±0.13 
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Table 3.4 AChE inhibition activity of the column fractions of ethyl acetate 
extract of C. sinensis 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 2.1±0.14 
2 Chloroform  10.1±0.22 
3 Chloroform-ethyl acetate (10:90) 9.5±0.16 
4 Chloroform-ethyl acetate (30:70) 11.6±0.29 
5 Chloroform-ethyl acetate (10:90) 37.2±0.19 
6 Ethyl acetate-methanol (98:02) 21.3±0.4 
 
3.2.3 Isolation of Hesperetin (2) 
Ethyl acetate extract of C. sinensis was loaded on a glass column packed with  silica gel  
and eluted with mixtures of  n-hexane, chloroform, ethyl acetate and methanol The 
results of AChE inhibition assay indicated, highest activity in the chloroform- ethyl 
acetate  (10:90) fraction which on preparative tlc (ethyl acetate-methanol, 97:03) yielded 
19 mg of hesperetin (2)  (0.004% yield). 
 
Spectral data 
UV (MeOH) λmax: 290, 302 nm 
IR (KBr, cm-1) υmax: 3411 (OH), 2900 (C-H), 1670 (C=O), 1535(C=C), 1170 (C-H). 
EIMS m/z (rel. int., %): 302 (M+, 100), 301 (24), 179 (15.1), 153 (31.1), 150 (45.3), 137 
(70.6), 135 (25.6). 
1H-NMR (MeOH, 500 MHz): δ 2.9 (2H, dd, J= 14.6Hz, 2.8 Hz, H-3), δ 3.9 (3H, s, H-7'), 
δ 5.5 (1H, m, H-2), δ 6.2 (1H, d, J=2.1 Hz, H-6), 6.25 (1H, d, J=2.1 Hz,H-08), δ 6.9 (H, 
dd, J= 1.8 Hz. 8.0 Hz, H-6'), δ 7.07 (H, d, J= 8.1 Hz., H-5').  
13C-NMR (MeOH, 125 MHz): δ 41.2 (C-3), δ 55.7 (C-4′), δ 78.4 (C-2), δ 95.3 (C-8), δ 
96.2 (C-6), δ 102.3 (C-10), δ 112.3 (C-5′), 113.3 (C-2′), δ 117.7 (C-6′), δ 131.3 (C-1′), δ 
146.6 (C-3′), δ 147.9 (C-4′), δ 162.9 (C-9'), δ 163.8 (C-5), δ 166.1 (C-7), δ 196.0 (C-4). 
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Table 3.5 AChE inhibition activity of the column fractions of methanol extract 
of C. sinensis 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 4.3±0.5 
2 Chloroform  11.6±0.34 
3 Chloroform-ethyl acetate (50:50) 19.6±0.32 
4 Chloroform-ethyl acetate (30:70) 24.2±0.6 
5 Chloroform-ethyl acetate (10:90) 31.4±0.39 
6 Ethyl acetate-methanol (98:02) 48.4±0.6 
 
3.2.4 Isolation of Hesperidin (3) 
Methanolic extract of C. sinensis was loaded to the silica gel column and elution was 
carried out with n-hexane, n-hexane-ethyl acetate and ethyl acetate-methanol. All the 
fractions were subjected to AChE screening. The fractions obtained in ethyl acetate-
methanol (98:02) was the most active fraction, which on preparative thin layer 
chromatography (ethyl acetate-methanol-water, 90:9.6:0.4) yielded 16 mg hesperidin (3) 
(0.003% yield). 
 
Spectral Data 
UV (MeOH) λmax: 285 nm 
IR (KBr , cm-1) υmax: 3427 (OH), 2913(CH), 1645 (C=O), 1519 (C=C), 1460(CH).  
FAB+ MS: 611, 465, 303, 277, 263,185,156. 
1H-NMR (MeOH, 500 MHz ) δ 6.99 (1H, m, H-5'), δ 6.9 (1H, m,  H-2'), δ 6.88 (1H, dd, 
J= 8.3,1.9 H-6'), δ 5.5 (1H, m, H-2) δ 5.2  (1H, d, J= 8.0, H-1''), δ 4.5  (1H, d, J= 8.0 H-
1'''), δ 3.8 (3H, s, H-7'), δ 3.6 (1H, m, H-5''), δ 3.5 (2H, m, H-6''), δ 3.4 (4H, m,  H-
4'',2''',3''',5'''), δ 3.3 (1H, m,  H-2'''), δ 3.2 (1H, dd, J=12.9Hz,3.3Hz,  H-3[b]), δ 3.2 (1H, 
m,  H-4''''), δ 3.1 (1H, m,  H-,3''), δ 2.5 (1H, dd, J=12.9, 3.3Hz,  H-3[a]), δ 1.0 (3H, m,  H-
6''')  
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13CNMR (MeOH,125 MHZ):δ 18.0 (C-6'''), δ 42.0 (C-3), δ 56.0 (C-4'), δ 68.1 (C-5''), δ 
69.3 (C-3'''), δ 69.7 (C-6''), δ 69.9 (C-2'''), δ 70.2 (C-4''), δ 72.8 (C-2''), δ 75.3 (C-5''), δ 
75.7 (C-3''), δ 78.1 (C-2), δ 95.8 (C-8), δ 96.6 (C-6), δ 99.6 (C-1''), δ 101.0 (C-1'''), δ 
103.6 (C-10, 5'), δ 114.5 (C-2'), δ 118.2 (C-6'), δ 131.4 (C-1'), δ 146.7 (C-3'), δ 148.2 (C-
4'), δ 162.8 (C-9'), δ 163.3 (C-5), δ 165.2 (C-7), δ 196.7 (C-4). 
Citrus sinensis
Soxhlet  Extraction
n-hexane Chloroform Ethyl acetate Methanol
Column Chromatography
n-hexane: Chloroform* 50:50 
Chloroform* 
Chloroform: ethyl acetae* 50: 50
Chloroform : ethyl acetate* 30:70
Chloroform : ethyl acetate* 10:90
Ethyl acetate : methanol* 98 : 02
Preprative tlc
Hesperetin (2)* 19 mg
ethyl acetate: methanol
97: 03
Preprative tlc
ethyl acetae : methanol: water
              90 : 9.3: 0.7    
Hesperidin (3)*  16mg
* subjected to AChE inhibition assay
 
Scheme 3.2 Extraction scheme of hesperetin (2) and hesperidin (3) from C. sinensis  
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3.3 Acacia catechu 
3.3.1 Collection and identification  
Fresh whole plant (5.83 kg) of Acacia catechu was collected from Lahore region 
Pakistan. The Plant was identified at the Department of Botany, GC University Lahore, 
Pakistan (GCU-BOT-268).  
3.3.2 Extraction and bioassay guided fractionation 
The air dried powdered plant material (500 g) was extracted with n-hexane, chloroform, 
ethyl acetate and methanol (2 L each) using soxhlet apparatus (scheme 3.3). All the 
extracts were concentrated under vacuum at room temperature and screened for 
acetylcholine esterase activity. The chloroform extract showed significant activity and 
subjected to silica gel column chromatography. Mixtures of hexane-chloroform, 
chloroform-ethyl acetate and ethyl acetate- methanol were used as eluents, according to 
increasing gradient polarity. Each fraction obtained as a result of column chromatography 
was dried and screened against AChE activity. The most active fraction was subjected to 
column chromatography for the isolation of compounds (table 3.6).  
Table 3.6 AChE inhibition activity of the extracts of Acacia catechu 
 
Sr. No. Extract (200µg/mL) AChE inhibition (%) 
01 n-hexane - 
02 Chloroform - 
03 Ethyl acetate 16.9±0.37 
04 Methanol 17.4 ±0.12 
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Table 3.7 AChE inhibition activity of the column fractions of ethyl acetate 
extract of C. sinensis 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 5.8±0.25 
2 Chloroform  9.1±0.17 
3 Chloroform-ethyl acetate (50:50) 14.4±0.23 
4 Chloroform-ethyl acetate (10:90) 34.1±0.29 
5 Ethyl acetate-methanol (98:02) 12.4±0.4 
 
3.3.3 Isolation of Catechin (4) 
The fraction collected in the system of chloroform-ethyl acetate (10:90) showed 
maximum AChE activity among all other fractions. Preparative tlc of the fraction in the 
system of  n-hexane-ethyl acetate (15:85)  yielded 16 mg catechin (4) (0.05% yield). 
 
Spectral Data  
UV (MeOH) λmax: 221, 277 nm 
FTIR (KBr , cm-1) υmax: 3400 (OH), 2923(CH), 1627 (C-O), 1500 (C=C),1470(CH).  
EIMS (m/z , rel. int., %): 290.0 (M+, 5.40), 152.0 (31.2), 139.1 (100), 123.1 (49.3),55.0 
(37.3). 
1H-NMR: (CDCl3, 500 MHz): δ 6.8 (H, d, J=7.8, H-5'), δ 6.7 (H, d, J=1.8, H-2'), δ 6.7 
(H, dd, J=7.8,1.8, H-6') , δ 5.93 (H, d, J=2.0, H-8), δ 5.85 (H, d,J=2.0, H-06), δ 4.6 (H, d, 
J=4.5, H-2). 
13C-NMR (CDCl3, 125 MHz): δ 28.7 (C-4), δ 68.1 (C-3), δ 82.9 (C-2), δ 94.5 (C-6), δ 
95.5 (C-8), δ 96.5 (C-10), δ 114.9 (C-5'), δ 116.1 (C-2'), δ 120.0 (C-6'), δ 132.6 (C-1'), δ 
146.3 (C-3'), δ 146.5 (C-4'), δ 156.9 (C-5),  δ 157.6 (C-7), δ 157.9 (C-09),. 
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Ethyl Acetate extract
Column Chromatography
n-hexane- Chloroform* (50:50) 
Chloroform* 
Chloroform- ethyl acetae* (50: 50)
Chloroform - ethyl acetate* (10:90)
Ethyl acetate - methanol* (98 : 02)
Preprative tlc
Catechin*  16 mg
ethyl acetate-methanol
           85:15
* subjected to AChE inhibition assay
A. catechu
methanol Chloroform n-hexane
Soxhlet extraction
 
Scheme. 3.3  Extraction scheme of catechin (4) from A. catechu 
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Table 3.8 AChE inhibition activity of the column fractions of the methanol 
extract of Acacia catechu 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-hexane-chloroform (75:25) 33.1±0.15 
2 Chloroform-ethyl acetate (30:70) 09.2±0.16 
3 Chloroform-ethyl acetate (50:50) 07.2±0.29 
4 Ethyl acetate-methanol (98:02) 22.4±0.3 
 
3.3.4 Isolation of Gallic acid (5) 
Methanolic extract of A. catechu showed 17.4 ±0.12 % AChE activity (table 3.7) which, 
further proceeded with silica gel column chromatography. The elution was carried out 
with n-hexane, chloroform-ethyl acetate and ethyl acetate-methanol. The fractions 
obtained in n-hexane-chloroform (75:25) were pooled, dried and rechromatographed (n-
hexane- ethyl acetate 40:60) which yielded 12 mg  gallic acid (5) as (0.004%). 
 
Spectral Data 
UV  λmax : 256 nm 
IR (KBr disc, cm-1) υmax: 3287 (CH), 1661 (C=O), 1204 (C=C).  
EIMS  m/z (rel. int., %):   170 (M+, 100), 153 (68.5), 126(16.9), 125 (15.4),79 (15.0), 51 
(12.5),39( 12). 
1H-NMR (CDCl3, 500 MHZ): 7.1 (2H, s,H-2,6) 
13C-NMR (CDCl3,125 MHZ): δ 110.9 (C-2, 6), δ 121.6 (C-1), δ 138.9 (C-4), δ 145.3 (C-
3,5), δ 170.9 (C-7). 
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3.3.5 Isolation of Tannic acid (6) 
Column chromatography of the methanolic extract of A. catechu (Scheme 3.4) yielded 
several fractions. The results of AChE inhibition assay indicated highest activity in the 
chloroform-ethylacetate fraction obtained in the ratio 5:95. Preparative tlc of this fraction 
in the system of ethyl acetate: methanol (85:15) yielded 18.5 mg  tannic acid (6) (0.001% 
yield). 
Spectral Data 
IR (KBr disc, cm-1): 2870, 2727, 1533 (C=O), 1087 (C=C), 957.  
FAB positive: 771, 619, 415, 369,277,185,107 
1H-NMR (CDCl3, 500 MHz):  δ 7.03 (2H, m,H-2,5), δ 6.63 (1H,m,H-2'), δ 5.5 (1H, m, 
H-4'), δ 5.03 (1H, m, H-3'), δ 4.35 (2H, s, H-6'), δ 3.86 (1H,m,H-5').  
13 CNMR (CDCl3, 125 MHz): δ 166.4 (C-7), δ 145.6 (C-3,5), δ 138.5 (C-4), δ 124.9 (C-
1), δ 110.4 (C-2), δ 93.9 (C-2'), δ 76.6 (C-4'), δ 72.4 (C-3'), δ 69.7 (C-6'), δ 67.7 (C-5'). 
 
Methanol extract of A. catechu
Column Chromatography
n-hexane: chloroform* 75:25 
Chloroform: ethyl acetae* 30: 70
Chloroform : ethyl acetate* 50:50
Ethyl acetate : methanol* 98 : 02
Preprative tlc
Tannic acid*  18.5 mg
ethyl acetate: methanol 
             85: 15
* subjected to AChE assay
Gallic acid* 12 mg
Preprative tlc
n-hexane:ethyl acetate
40: 60
 
Scheme  3.4  Isolation of gallic acid and tannic acid from A. catechu 
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3.4 Melia azedarach 
3.4.1 Collection and identification  
Whole plant of M. azedarach (6.8kg) was collected from Muree  region Pakistan. The  
plant was identified at the Department of Botany, GC University Lahore where a voucher 
specimen (GCU-BOT-395) was submitted.  Plant material was air dried under shade and 
then grinded. 
3.4.2 Extraction and bioassay guided fractionation 
The grinded plant material was extracted successively with n-hexane, chloroform, ethyl 
acetate and methanol (2 L each) using soxhlet apparatus. All the extract were 
concentrated under vacuum and screened for acetylcholine esterase activity using 
Ellman’s method [128]. The ethyl acetate extract showed significant activity (table 3.9) 
was loaded on a glass column packed with silica. Mixtures of n-hexane-chloroform, 
chloroform-ethyl acetate and ethyl acetate- methanol were used as eluents (Scheme 3.5). 
All collected fractions were dried and screened against AChE activity and the results are 
shown in table 3.9. 
Table 3.9 AChE inhibition activity of the extracts of Melia azedarach 
 
S. No. Extract (200µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 1.2±0.23 
03 Ethyl acetate 16.1± 0.09 
04 Methanol 9.3±0.23 
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Table 3.10 AChE inhibition activity of the CC fractions of ethyl acetate extract of 
M. azedarach 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (20:80) 23.1±0.3 
2 Chloroform  06.1±0.4 
3 Chloroform-ethyl acetate (50:50) 09.4±0.3 
 
3.4.3 Isolation of Vanillin (7)   
Ethyl acetate extract of Melia azedarach was loaded on the column packed and  eluted 
with gradient mixtures of n-hexane, chloroform and ethyl acetate which resulted in total 
45 fractions. The fractions obtained in n-hexane-chloroform (20:80) were selected on the 
basis of AChE inhibition activity. The fractions were pooled, dried and 
rechromatographed using preparative tlc which yielded 5.5 mg vanillin (7) (0.001% 
yield). 
 
Spectral Data 
UV (MeOH) λmax: 225, 260 nm. 
IR (KBr, cm-1) υmax: 3439 (OH), 2832 (CH), 1680 (C=O), 1509 (C=C), 1105 (CH). 
EIMS m/z (rel. int., %): 152.1(M+, 6.70), 123.1 (5.12), 109.1 (15.45), 92.1 (2.14), 81.0 
(63.90), 62.0 (30.33), 51.0 (100).  
1H-NMR (CDCl3, 500 MHz): δ 3.93 (3H, s, ArOMe), δ 7.07 (1H, d, J= 8.1 Hz, H-5), δ 
7.45 (1H, d, J= 1.8 Hz, H-2), δ 7.47 (1H, dd, J= 8.1, 1.8 Hz, H-6), δ 9.85 (1H, s, H-7). 
13C-NMR (CDCl3, 125 MHz): δ 56.11 (ArOMe), δ 108.94 (C-6), δ 114.46 (C-3), δ 
127.50 (C-4), δ 129.85 (C-5), δ 147.22 (C-1), δ 151.79 (C-2), δ 190.95 (C-7). 
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ethyl acetate extract 
Column Chromatography
n-hexane: Chloroform* 20:80 
Chloroform* 
Chloroform: ethyl acetae* 50: 50
* subjected to AChE assay
Preprative TLC
n-hexane:ethyl acetate
15:85
M. azedarach
Methanol Chloroform
n-hexane
Soxhlet extraction
Vanillin* 5.5 mg
 
Scheme  3.5 Isolation of Vanillin from M. azedarach 
 
3.5 Impatiens bicolor 
3.5.1 Collection and identification 
Fresh whole plant (5.2 kg) of I. bicolor was collected from Ayubia Park Muree, Pakistan. 
The plant was identified at the Department of Botany, GC University Lahore (GCU-
BOT-225).   
3.5.2 Extraction and bioassay guided fractionation 
The powdered plant material was extracted successively with n-hexane, chloroform, ethyl 
acetate and methanol using soxhlet apparatus. All the extracts were concentrated under 
vacuum at room temperature and screened for acetylcholine esterase activity using 
Ellman’s method at a concentration of 200μg/mL concentration. The ethyl acetate extract 
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showed good activity (table 3.11) and proceeded further for the isolation of compounds. 
The ethyl acetate extract subjected to Si gel column chromatography. The column was 
successfully eluted with the mixtures of hexane, chloroform, ethyl acetate and methanol 
and screened against AChE activity (table 3.12).  
Table 3.11 AChE inhibition activity of the extracts of Impatiens bicolor 
S. No.  Extract (200µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 11.2±0.37 
03 Ethyl acetate 24.5±0.45 
04 Methanol 14.1±0.14 
 
 
Table 3.12 AChE inhibition activity of the column fractions of ethyl acetate 
extract of I. bicolor 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 2.1±0.15 
2 Chloroform  8.8±0.27 
3 Chloroform-ethyl acetate (75:25) 36.2±0.19 
4 Ethyl acetate-methanol (98:02) 08.2±0.4 
 
3.5.4 Isolation of ferulic acid (8) 
Preliminary screening of the extracts of I.bicolor in the AChE inhibition assay showed 
significant results (table 3.11) in the ethyl acetate extract, which further subjected to 
column chromatography and the fractions were subjected to AChE assay. The fraction in 
chloroform-ethyl acetate (25:75) showed highest activity and were pooled, dried and 
rechromatographed (n-hexane: ethyl acetate : 30: 70)  which yielded ferulic acid (8) as 
white crystal ( 17 mg, 0.001% yield). 
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The X-Ray analysis of the isolated compound was carried out on Bruker KAPPA APEX 
II diffractometer using Mo Kα X-ray (0.71073 Å) source and a graphite monochromator 
[117].  
 
ethyl acetate 
Column Chromatography
n-hexane: Chloroform* (50-50) 
Chloroform* 
Chloroform: ethyl acetae* (75-25)
Ethyl acetate : methanol* (98 - 02)
* subjected to AChE inhibition assay
n-hexane: ethyl acetate
            30: 70
Preprative tlc
Ferulic acid* 17 mg   
I. biocolor
Methanol Chloroform n-hexane
Soxhlet extraction
 
Scheme . 3.6  Extraction of ferulic acid (8) from I. bicolor 
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Table 3.13. X-ray crystal data of ferulic acid(8). 
Formula C10H10O4 
Formula weight 194.18 
Crystal system Monoclinic 
Space group P21/n 
a, b, c (Å) 4.6351 (8), 16.797 (2), 11.9958 (17) 
Α, β, γ (deg) 90.00, 90.155 (7), 90.00 
V (Å3) 933.9 (2) 
Z 4 
ρ calc (g cm–3) 1.38 
μ(MoKα) (mm-1) 0.108 
F(000) 408 
Crystal size (mm) 0.38x 0.22x 0.14 
Temperature (K) 296 
λ MoKα (Å) 0.71073 
θ range (deg) 2.4- 28.40 
3.6 Cinnamomum zeylanicum 
3.6.1 Collection and identification  
Bark of C. zeylanicum was purchased from local market Lahore, and identified (GCU-
BOT-107) at Sultan herbarium, Department of Botany, GC University Lahore, Pakistan.  
Plant material was air dried, and grinded to powder. 
3.6.2  Extraction and bioassay-guided fractionation 
Powdered plant material was extracted successively with n-hexane, chloroform, ethyl 
acetate and methanol using soxhlet apparatus. All the extracts were concentrated under 
vacuum and screened for acetylcholine esterase activity (table 3.14). The ethyl acetate 
extract showed significant activity and proceeded further for the isolation of compounds. 
The ethyl acetate extract subjected to Si gel column chromatography. Gradient mixtures 
of hexane, chloroform and ethyl acetate were used as eluents.  
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Table 3.14 AChE activity of the extracts of Cinnamomum zeylanicum 
S. No.  Extract (200µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 10.4± 0.12 
03 ethyl acetate 21.7±0.19 
04 Methanol 9.6±0.26 
 
 
Table 3.15 AChE inhibition activity of the CC of ethyl acetate extract of C. 
zelaynicum 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 7.1±0.15 
2 Chloroform  10.8±0.27 
3 Chloroform-ethyl acetate (90:10) 25.2±0.15 
 
3.7.3  Isolation of Cinnamic acid(9) 
Ethyl acetate extract of Cinnamomum zeylanicum exhibited maximum 21.7± 
0.19%AChE inhibition activity and loaded to the Si packed column and elution was 
carried out with n-hexane, chloroform, and ethyl acetate successively. The fractions 
collected in the system of chloroform: ethyl acetate 90:10 (25.2 ±0.15 % AChE activity), 
after drying were subjected to preparative tlc system (n-hexane: ethyl acetate 30:70) 
which resulted in cinnamic acid (9) (14 mg, 0.004% yield)  
The X-Ray analysis of the isolated compound was carried out on Bruker KAPPA APEX 
II diffractometer using Mo Kα X-ray (0.71073 Å) source and a graphite monochromator 
[129]. 
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ethyl acetate 
Column Chromatography
n-hexane: Chloroform* 70:30 
Chloroform* 
Chloroform: ethyl acetae* 90:10
* subjected to AChE inhibition assay
n-hexane: ethyl acetate
            30: 70
Preprative tlc
Cinnamic Acid* 14 mg   
C.zeylanicum
Methanol
Chloroform n-hexane
Soxhlet extraction
 
Scheme 3.7 Isolation of cinnamic acid (9) from C. zeylanicum 
 
Table 3.16   Crystal data of cinnamic acid (9) 
Formula C9H8O2 
Formula weight 148.15 
Crystal system Monoclinic 
Space group P21/n 
a, b, c (Å) 5.6430 (12), 18.0028 (4), 7.7414 (15) 
α, β, γ (deg) 90.00, 96.865 (11), 90.00 
V (Å3) 780.8 (3) 
Z 4 
ρ calc (g cm–3) 1.260 
μ(MoKα) (mm-1) 0.089 
F(000) 312 
Temperature (K) 296 
λ MoKα (Å) 0.71073 
θ range (deg) 2.1- 28.12 
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3.7  Artemisia vulgaris 
3.7.1  Collection and identification  
Whole plant of A. vulgaris was collected from Ayubia park Muree, Pakistan. Plant 
material was identified at the Department of Botany, GC University Lahore (GCU-BOT-
495). 
3.7.2  Extraction and bioassay-guided fractionation 
The air dried powdered plant material was extracted with n-hexane, chloroform, ethyl 
acetate and methanol successively using soxhlet apparatus. All the extracts were 
concentrated under vacuum and screened against AChE using Ellman’s method at a 
concentration of 200μg/mL.  
 
Table 3.17 AChE inhibition activity of the extracts of Artemisia vulgaris 
 
S. No. Extract(200µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 13.7± 0.06 
03 Ethyl acetate 6.8±0.13 
04 Methanol 9.1±0.19 
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Table 3.18 AChE inhibition activity of the CCfractions of the chloroform extract 
of A. vulgaris 
S. No Fractions (200µg/mL) AChE inhibition (%) 
1 n-Hexane-chloroform (50:50) 5.1±0.15 
2 Chloroform  11.8±0.27 
3 Chloroform-ethyl acetate (75:25) 49.5±0.19 
4 Chloroform-ethyl acetate (50:50) 12.6±0.16 
 
3.7.3  Isolation of Artemisinin (10) 
The chloroform extract of A. vulgaris showed significant AChE inhibitory activity in 
table 3.17 and was further subjected to column chromatography in silica packed column 
and elution was carried out through n-hexane, chloroform and ethyl acetate. The fractions 
obtained in chloroform-ethyl acetate (25:75) were pooled (table 3.18), dried and 
rechromatographed in n-hexane: ethyl acetate (30: 70) which yielded 15 mg  
artemisinin((10) (0.005% yield).   
 
Spectral Data 
UV (MeOH) λmax: 212nm 
IR (KBr, cm-1) υmax: 2895 (C-H), 1732 (C=O), 1045 (C-H). 
EIMS m/z (rel. int., %): 282.2 (M+, 10.12), 167.0 (34.62), 149.0 (100), 113.1 (10.92), 
78.9 (28.67), 57.0 (56.82).  
1H-NMR (CDCl3,500 MHz):  δ 2.0 (2H, m, H-4, 5[a]), δ 2.4 (2H, m, H-4,5[b]), δ 1.4 (H, 
m,H-6), δ 1.9 (2H, m,H-8), δ 1.2 (2H, m,H-9), δ 1.7 (1H, m,H-10), δ 3.3 (1H, m,H-11), δ 
5.8 (1H, s,H-14), δ 1.18 (3H, d,J=7.6, H-16), δ 0.98 (3H, d,J=6.0 H-17), δ 1.55 (3H, s,H-
18).   
13C-NMR (CDCl3,125 MHz): δ 12.5 (C-16), δ 19.8 (C-17), δ 23.4 (C-9), δ 24.8 (C-5),δ 
25.1 (C-18), δ 32.9 (C-8), δ 34.0 (C-4), δ35.8 (C-7), δ 38.9 (C-11), δ 44.0 (C-10), δ 50.1 
(C-6), δ 80.0 (C-15), δ 93.3 (C-14), δ 105.4 (C-3), δ 172.3 (C-12). 
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ethyl acetate 
Column Chromatography
n-hexane: Chloroform* 70:30 
Chloroform* 
Chloroform: ethyl acetae* 75:25
Chloroform : ethyl acetate* 50:50
* subjected to AChE assay
n-hexane: ethyl acetate
            30: 70
Preprative TLC
Artemisinin* 15 mg   
 A.vulgaris
methanol chloroform n-hexane
soxhlet extraction
 
Scheme 3.8  Isolation of artemisinin from A.vulgaris 
3.8  Acetylcholine esterase (AChE) assay 
Acetylcholine esterase inhibitory activity of the crude extract/compounds was measured 
by the spectrophotometric method developed by Ellman et al [128] . Acetylcholine iodide 
was used as the substrate to assay acetylcholine esterase. 1500 µL of (100 mM) tris 
buffer (pH 7.8), 1000 µL of DTNB (3µM) , 200 µL (50,100,150,200,250 µg/mL ) of the 
sample solution in tris buffer and 200 µL of acetylcholine iodide (15µM) ) solution in tris 
buffer,  were mixed and incubated for 15 minutes (25oC). The reaction was initiated by 
the addition of 200 µL acetylcholine esterase (enzyme). Erythrocytes from blood were 
diluted to 60 folds by using tris buffer and freeze again. The frozen material was again 
sonicated and diluted to 9 folds with the tris buffer. The hydrolysis of acetylcholine was 
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monitored by the formation of yellow 5-thio-2-nitrobenzoate anion as the result of the 
reaction of DTNB with thiocholine, released by the enzymatic hydrolysis of 
acetylcholine. The reaction was monitored at 412 nm for 30 minutes. Test samples and 
the positive control (Galanthamine) were dissolved in tris buffer. All the reactions were 
performed in triplicate, The percentage inhibition was calculated as (E – S)/ E x 100, 
where E is the activity of the enzyme without test  and S is the activity of enzyme with 
test compound.    
3.9  Enzyme kinetic assay 
The enzyme kinetic assay of compounds was performed using Ellman’s method with 
some modification. The reaction mixture contained 1500 µL of (100 mM) tris buffer (pH 
7.8), 1000 µL of DTNB, 200 µL (0.001, 0.002, 0.003, 0.006, 0.012µM) of test-compound 
solution and 200 µL (2.5, 5.0, 7.5, 10.0, 12.5, 15.0 µM) of acetylthiocholine iodide 
solution, which were mixed and incubated for 15 minutes (25oC). The reaction was then 
initiated by the addition of 200 µL acetyl cholinesterase. The hydrolysis of acetyl 
cholinesterase was monitored by the formation of yellow 5-thio-2-nitrobenzoate anion as 
the result of the reaction of DTNB with thiocholine, released by the enzymatic hydrolysis 
of acetylthiocholine and at a wavelength of 412 nm (30 min.).  The kinetic graphs were 
obtained by using GraFit 7.0 software. 
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RESULTS & DISCUSSION 
  
4.1 AChE activity of the extracts of Datura innoxia 
Initial screening of the crude extracts showed that extract obtained at pH9.0 exhibited 
highest 35.9±0.18% acetylcholine esterase inhibition activity (Table 4.1). The extract was 
further subjected to bioassay guided fractionation using column chromatography.   
   
Table 4.1  Acetylcholine esterase activity of the extract of the Datura innoxia 
Sr. No.  Extract (200µg/mL) AChE inhibition % 
01  
CHCl3 
pH: 7.0  3.2±0.29 
02 CHCl3 pH: 3.0  7.3±0.11 
03 CHCl3 pH: 9.0  35.9±0.18 
04 n-butanol extract 12.9±0.31 
 
4.1.1  Isolation and characterization  of Scopolamine (1) 
 The chloroform-ethyl acetate (50:50) fraction which exhibited highest inhibitory activity, 
on preparative tlc, yielded scopolamine (1). The compound showed maxima at 235nm in 
the UV spectrum, while IR spectrum showed a broad peak between 3345-3150 cm-1 due 
to C-N and –OH stretching [118]. Molecular ion peak of the compound appeared at m/z 
303.1, while the other fragments at m/z 154.1, 138.1, 108.1, 94.1, 57.0.  The mass 
fragmentation pattern of the compound was in accordance with the literature [119]. 
 The 1H-NMR (CDCl3, 400 MHz) spectrum of compound showed eleven hydrogens. The 
signals at δ 3.89 (H-5',4',3',6') and a very strong signal at δ 2.83 (H-8') were assigned with 
the help of HMQC spectrum together with the strong signals at δ 7.34, 7.06 due to 
benzene ring indicated the presence of scopolamine skeleton. 
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The 13C-NMR spectrum of scopolamine (1) showed twelve signals in total.  The signals 
at δ 64.5, 55.9, 58.4, 58.1 and 29.1 indicated the presence of tropine ring in compound 
[1]. The signal at 172.01 was assigned to the carbonyl carbon present in the ester linkage 
[4]. The signal at δ 137.3, 130.0, 127.2, 129.4, were assigned to the aromatic carbons. 
 
 
 
 
 
 
 
 
 
 
    Scopolamine (1) 
 
Table 4.2    AChE inhibition activity of Scopolamine (1) 
Sr. No. Concentration 
(μg/ml) 
AChE Inhibition % 
01 50 20.3±0.19 
02 100 39.1±0.27 
03 150 49.1±0.14 
04 200 63.9±0.25 
05 250 69.5±0.53 
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Fig.4.1   AChE inhibition activity of Scopolamine (1) 
 
4.1.2 Enzyme Kinetic Study of Scopolamine (1) 
         
 Fig 4.2  Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  scopolamine (1). 
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The results of scopolamine (1) showed that it exhibits mix type of inhibition against 
AChE with Ki values   -557, -576, -618, -1003, -906, for 2.5x 103, 5.0 x 103, 7.5 x 103, 
10.0 x 103, 15.0 x 103 µM substrate concentration respectively.  
4.2 AChE activity of the extracts of Citrus sinensis 
Ethyl acetate and methanol extracts of Citrus sinensis showed good AChE inhibition 
activity in initial screening and were further subjected to column chromatography for the 
isolation of hesperetin(2)  and hesperidin (3) 
 
Table 4.3  AChE inhibition activity of the extracts of  Citrus sinensis 
S. No.  Extract 
200 µg/mL 
AChE inhibition % 
01 n-hexane 0.0 
02 Chloroform 1.3± 0.24 
03 Ethyl acetate 13.2± 0.48 
04 Methanol 19.4±0.13 
   
4.2.1  Isolation and Characterization of Hesperetin (2) 
Ethyl acetate extract of Citrus sinensis was loaded to the column and elution was 
carried out with n-hexane, chloroform, ethyl acetate, and methanol. The fractions 
obtained in chloroform-ethyl acetate (10:90) yielded hesperidin (2).The maxima at 290 
and 302 nm in the UV spectrum indicated the presence of flavanone skeleton in 
compound (2) [120]. A broad peak at 3411 cm-1 was due to –OH and a characteristic 
carbonyl peak at 1670 cm-1  in the IR spectrum. EIMS spectrum of  compound 2 showed 
M+ at m/z 302.0 and fragment ions at m/z 179.0, 153.0, 150.0 and 137.0. HREIMS 
confirmed the formula as C16H14O6 [121]. The EIMS spectrum of the compound was in 
accordance with the Justesen. U (2000) [122].The 1H-NMR spectrum of  compound 2 
showed aromatic protons characterized by 1H integration,  at δ 2.9 , 3.8, 5.5, 6.2, 6.25and 
6.9 which confirmed the presence of flavanone skeleton and [122]. 
 59 
The 13C-NMR spectrum of the compound (2) showed signals at δ 196.0, δ 166.1, δ 163.8, 
δ 162.9 and δ 147.9.  The signal at δ 146.6, δ 131.3, δ 117.7, δ 113.3, δ 112.3, δ 102.3, δ 
96.2, δ 95.3, δ 78.4, δ 55.7, δ 41.2 indicated the presence of flavanone ring present in the 
compound structure. 
 
 
 
 
 
 
 
 
Hesperetin (2) 
 
 
Table 4.4             AChE inhibition activity of hesperetin (2) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 19.1±0.09 
02 100 24.1±0.12 
03 150 29.0±0.05 
04 200 34.7±0.06 
05 250 35.2±0.11 
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Fig 4.3 AChE inhibition activity of hesperetin (2) 
 
4.2.2  Isolation and Characterization of Hesperidin (3) 
The screening of column chromatography fraction of methanolic extract indicated 
48.4±0.6% AChE inhibition potential in the ethyl acetate-methanol (98:02) fraction (table 
3.5). The fraction was subjected to preparative tlc (ethyl acetate: methanol: water 
90:9.3:0.7) which yielded hesperidin (3) as light yellow powder.  
UV spectrum of compound (3) showed a maxima at 285 nm which is a characteristic of 
flavanone skeleton and a broad peak at 3427 cm-1 and at 1645 cm-1 confirmed the 
presence of –OH group and carbonyl group in the compound [120]. The ions of the 
protonated molecule [M+H]+ (m/z 611), the fragment ion [A1+H]
+ (m/z 449) 
corresponded to the loss of a glucose unit [M+H-(162)] and the protonated aglycone  
atm/z 303 followed by  the loss of rhamnosylglucose [124]. The molecule ion has a 
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markedly high relative abundance, which was unique as a flavanone 7-O-diglycosides 
[124]. The details of the spectroscopic results are given in the experimental section. 1H-
NMR spectrum of the compound (3) showed a singlet at δ 3.81 due to –OCH3 group and 
four doublet signals at δ 4.51, δ 5.23, δ 6.12 and  δ 6.10 and one doublet-doublet at δ 6.88 
(J= 8.3, 1.9 Hz) of the aromatic methine which were confirmed through HMQC 
spectrum[120] 
 
 
 
 
 
 
 
 
 
 
 
Hesperidin (3) 
 
Table 4.5         AChE inhibition activity of Hesperidin (3) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition % 
01 50 10.1±0.14 
02 100 19.6±0.29 
03 150 34.8±0.18 
04 200 55.4±0.32 
05 250 59.7±0.26 
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Fig. 4.4 AChE inhibition activity of  Hesperidin (3) 
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4.2.3 Kinetic Study of Hesperidin (3) 
 
Fig. 4.5 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  hesperidin (3). 
 
The results of hesperidin (3) showed a mixed type inhibition against AChE with Ki 
values -572, -859 , -864, -806, -741, for 2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 x 
103 µM substrate concentration respectively.  
4.3  AChE activity of crude extracts of Acacia catechu 
Preliminary screening of the extracts against AChE showed that ethyl acetate and 
methanol extracts posses AChE inhibition potential which were preceded further for the 
isolation of active compounds through column chromatography. 
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 Table 4.6  AChE inhibition activity of the extract of the Acacia catechu 
 
S. No.  Extract 
(200 µg/mL) 
AChE inhibition 
%S 
01 n-hexane - 
02 Chloroform - 
03 Ethyl acetate 16.9±0.37 
04 Methanol 17.4 ±0.12 
 
4.3.1 Isolation and Characterization of Catechin (4) 
Preparative tlc of the fraction obtained in the system of chloroform-ethyl acetate (10:90) 
obtained (scheme 3.3) resulted in the isolation of catechin (4) as a white powder 
(16.0mg). 
UV spectrum of compound (4) showed two characteristic maxima at 221 and 277 nm 
which indicated the flavan skeleton in the molecule [125]. The board peak at 3400 cm-1in 
the IR spectrum confirmed the presence of –OH group. The 13CNMR spectrum of the 
compound showed signals at δ157.9, δ116.1, δ114.9, δ 95.5, δ 94.5, δ 82.9, δ 68.1 and δ 
28.7. 1HNMR spectrum (CDCl3, 500 MHz) displayed  signals of aromatic protons at δ 
6.8, δ 6.7. while characteristic peaks of the proton of H-2, H-3 and H-4 appeared at δ 4.6, 
δ 5.8  and δ 5.93 respectively. EIMS spectrum indicated M+ at m/z 290.0 and other 
significant peaks at m/z 152.0, 139.1, 123.1 and 55.0. 
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Table 4.7    AChE inhibition activity of Catechin (4) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 1.5±0.46 
02 100 3.4±0.31 
03 150 4.9±0.38 
04 200 6.5±0.16 
05 250 8.5±0.24 
 
 
 
 
Fig. 4.8 AChE activity of the Catechin (4) 
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4.3.2 Isolation and Characterization of Gallic acid (5) 
The fraction collected in the system of n-hexane-chloroform (75:25) showed 33.1± 0.15 
AChE inhibition potential. This fraction on preparative tlc (n-hexane: ethyl acetate: 
40:60) yielded of gallic acid 12 mg. 
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Gallic Acid (5) 
 
The UV spectrum of compound 5 showed maxima at 256 nm which is a characteristic of 
benzene ring [126].  The IR spectrum of the compound 5 confirmed the presence of –
C=O group due to the peak at 1661 cm-1 and 1204 cm-1  for  -C=C-  functional groups in 
the compound[127]. EIMS spectrum of the compound showed M+ at m/z 170.0 and 
fragment ions at m/z 153.0, 126.0, 79.0, 51.0. HREIMS confirmed the formula as 
C6H6O3. The 
1HNMR spectrum showed a strong singlet at δ 7.1 due to aromatic protons 
and a downfield signal at δ 12.0 which indicated –COOH group.  The 13CNMR spectrum 
of the compound showed signal δ 170.98  due to the –COOH, while the δ 145.35 was due 
to C-3,5attached with –OH group and δ 138.97 due to C-4 which confirmed that the 
compound was gallic acid 5. 
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Table 4.8 AChE inhibition activity of Gallic acid (5) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 12.4± 0.08 
02 100 19.8± 0.15 
03 150 22.8± 0.29 
04 200 29.9± 0.38 
05 250 36.1± 0.21 
 
 
 
Fig. 4.9 AChE activity of gallic acid (5) 
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4.3.3 Kinetic Studies of Gallic Acid (5) 
 
 
Fig. 4.10 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  gallic acid (5). 
 
The results of gallic acid (5) indicated uncompetitive  inhibition against AChE with Ki 
values -681, -592, -624, -637, -774  for 2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 x 
103 µM substrate concentration respectively.   
 
  
 69 
4.3.4 Isolation and Characterization of Tannic acid (6) 
-C=O, C=C functional groups in the compound were confirmed due to the presence of 
signals at  1530 cm-1, 1087 cm-1 in the IR spectrum. The 13CNMR spectrum of the 
compound showed signals at δ 166.4, 145.6, 138.5, 124.9,108.5, 94.6, 79.7, 69.7, 68.7 , 
67.7 and 1HNMR showed signals in the spectrum at δ 7.83, δ 7.15, δ 6.62, δ 5.5, δ 5.03, δ 
4.3,  δ 3.82  with reported values [128]. Therefore the compound was identified as tannic 
acid(6). 
 
 
 
Tannic acid (6) 
 
Table 4.9        AChE activity of Tannic Acid(6) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 12.4±0.31 
02 100 23.7±0.28 
03 150 33.9±0.19 
04 200 40.7±0.39 
05 250 43.2±0.58 
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Fig. 4.11   AChE activity of Tannic Acid (6) 
4.3.5 Kinetic Study of Tannic Acid 
 
Fig. 4.12 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  tannic acid (6). 
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The results of tannic acid(6) showed a mix type inhibition against AChE with Ki values  -
320, -367, -362, -398, -389 for 2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 x 103 µM 
substrate concentration respectively.  
4.4  AChE activity of crude extract of Melia azedarach 
Ethyl acetate extract of Melia azedarach showed high AChE inhibition potential in the 
initial AChE screening and further subjected to column chromatography, followed by 
preparative tlc, which yielded vanillin (7) as white powder. 
 
Table 4.10  AChE inhibition activity of the extracts of Melia azedarach 
S. No.  Extract 
200 µg/mL 
AChE inhibition % 
01 n-hexane 0.0 
02 Chloroform 1.2±0.23 
03 Ethyl acetate 16.1± 0.09 
04 Methanol 9.3±0.23 
 
4.4.1 Isolation and Characterization of Vanillin (7) 
Ethyl acetate extract of Melia azedarach was loaded on column packed with silica, the 
column was eluted with  n-hexane-chloroform, chloroform , chloroform-ethyl acetate, 
ethyl acetate. The fractions obtained in n-hexane-chloroform (20:80) were pooled, dried 
and rechromatographed which yielded vanillin(7).  
The EIMS spectrum fragmentation of the isolated compound confirmed the 
presence of an aldehyde group. The simple cleavage of hydrogen ion attached to carbonyl 
group resulted in the base peak at m/z 151 [M-1]+. The observation of strong peak at m/z 
109 is due to the cleavage of CO from fragmented species after β cleavage of aromatic 
ring to yield [hydroxyl-aldehyde-C5H5]
+ and m/z 80 is fragmented by both m/z 152 and 
m/z 151 routes. These results are in accordance of Nang et al [129] which confirmed that 
the compound was vanillin (7). 
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    Vanillin (7) 
Table 4.11 AChE inhibition activity of vanillin (7) 
 
S. No. Concentration 
(μg/ml) 
% AChE 
Inhibition 
01 50 10.5±0.18 
02 100 21.3±0.24 
03 150 34.5±0.53 
04 200 46.7±0.37 
05 250 50.4±0.17 
 
 
Fig. 4.13  AChE inhibition activity of  Vanillin (7) 
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4.4.2 Kinetic Study of Vanillin (7) 
 
Fig. 4.14 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  Vanillin (7). 
 
The results of vanillin showed that it show uncompetitive inhibition against AChE with 
Ki values   -235, -316, -423, -474, -497 for 2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 
x 103 µM substrate concentration respectively.  
4.5 AChE activity of crude extract of Impatiens bicolor 
Initial screening of AChE inhibition of crude extracts of I. bicolor showed highest 
potential in the ethyl acetate extract which was further preceded to column 
chromatography for the isolation of ferulic acid(8). 
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Table 4.12  AChE inhibition activity of the extracts of the Impatiens bicolor 
S. No.  Extract 
200 µg/mL 
AChE inhibition 
% 
01 n-hexane 0.0 
02 Chloroform 11.2±0.37 
03 Ethyl acetate 24.5±0.45 
04 Methanol 14.1±0.14 
 
4.5.1 Isolation and characterization of ferulic acid (8) 
The various extracts of Impatiens bicolor were obtained by soaking the whole plant in 
different solvents with increasing order of solvent polarity, in the sequence n-hexane, 
chloroform, ethyl acetate and methanol. The ethyl acetate extract was further subjected to 
column chromatography in silica packed column. The fractions obtained in chloroform-
ethyl acetate (25:75) were pooled, dried and rechromatographed which yielded ferulic 
acid [130]  
The structure of ferulic acid (8) was not planer overall, with the maximum deviation for 
the oxygen atoms i.e. 0.0602 (0.0014) Å for O2 and 0.0907 (0.0015) Å for O3. The 
dihedral angle deviation was 3.51 (0.13) Å between phenyl group and allylic groups. The 
compound was further stabilized by the formation of C---H…O types inter and 
intramolecular hydrogen bonding via formation of dimmers through the carboxyl group is 
a characteristic property of this type of functional group. The crystal data is shown in 
Table 3.13. 
The X-ray crystallographic studies confirm the compound was ferulic acid (8) [131].  
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OH CH3
O OH
 
Ferulic Acid (8) 
 
 
Fig. 4.15 X-ray Structure of Ferulic Acid (8) 
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Table 4.13      AChE inhibition activity of Ferulic Acid (8) 
 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 12.4±0.17 
02 100 23.8±0.29 
03 150 33.2±0.09 
04 200 42.9±0.25 
05 250 44.3±0.36 
 
 
 
Fig.4.16   AChE inhibition activity of the Ferulic Acid (8) 
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4.5.2 Kinetic study of Ferulic acid (8) 
 
 
Fig. 4.17 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  ferulic acid (8). 
 
The results of ferulic acid showed uncompetitive inhibition against AChE with Ki values 
-465, -517, -567, -608, -668, for 2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 x 103 µM 
substrate concentration respectively.  
4.6 AChE activity of crude extracts of Cinnamomum zeylanicum 
Ethyl acetate extract was proceed to column chromatography for the isolation of 
cinnamic acid as the extract showed highest AChE inhibition in the initial screening. 
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Table 4.14  AChE inhibition activity extracts of  C. zeylanicum 
S. No. Extract (200 µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 10.4± 0.12 
03 Ethyl acetate 21.7±0.19 
04 Methanol 9.6±0.26 
4.6.1  Isolation and characterization of cinnamic acid (9) 
The various bark extracts of Cinnamomum zeylanicum were obtained by soaking the 
whole plant in different solvents with increasing order of solvent polarity, in the 
sequence; n-hexane, chloroform, ethyl acetate and methanol. The ethyl acetate extract 
showed significant AChE inhibitory activity and was further subjected to column 
chromatography in silica packed column. The fractions obtained in chloroform-ethyl 
acetate (10:90) were pooled, dried and rechromatographed which yielded cinnamic acid (9).  
X-rays  data analysis results showed that cinnamic acid (9) as an overall was not planer 
with the maximum deviation for both the oxygen atoms i.e. 0.0948 (0.0030) Å for O1 and 
-0.0749 (0.0031) Å for O2. The phenyl group and allylic groups are oriented at dihedral 
angle of 6.36 (0.24) Å. A dimmer was formed through carboxylic group which stabilized 
the structure of the molecule that is the characteristic property of the carboxyl functional 
group The single crystal crystallographic studies confirm the compound was cinnamic 
acid [9].  
 
Fig. 4.18   X- Ray structure of Cinnamic acid (9) 
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Table 4.15 AChE inhibition  activity of Cinnamic Acid (9) 
S. No. Concentration 
(μg/ml) 
AChE Inhibition 
% 
01 50 2.6± 0.17 
02 100 6.8±0.21 
03 150 11.4± 0.14 
04 200 14.9±0.38 
05 250 19.7±0.19 
 
 
Fig. 4.19  AChE inhibition activity of  Cinnamic Acid (9) 
4.7 AChE activity of crude extracts of Artemisia vulgaris 
AChE activity of the crude extract of Artemisia vulgaris were screened at a concentration 
of 200 µg/mL. Ethyl acetate extract showed significant AChE inhibition which was 
proceeded to column chromatography for the isolation of artemisinin. 
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Table 4.16  AChE inhibition activity of extracts of Artemisia vulgaris 
S. No.  Extract (200 µg/mL) AChE inhibition (%) 
01 n-hexane 0.0 
02 Chloroform 1.7± 0.06 
03 Ethyl acetate 13.8±0.13 
04 Methanol 9.1±0.19 
 
4.7.1 Isolation and Characterization of  Artemisinin (10) 
The EIMS mass spectrum of the compound showed M+ at m/z 282.0  while the other 
characteristics peaks at m/z 192.0, 151.0, 122.1, 81.0 which were corresponded to its 
molecular formula. IR spectrum of the compound showed sharp peaks at 2895 and 1732 
due to C-H and C=O stretching vibrations. 1HNMR spectrum of the compound (10) 
exhibited two doublet signals at δ 0.98 and δ 1.18 with J=7.6 and 6.0 Hz respectively. 
The other signals in multiplets form were highly shielded δ 1.20-3.33 and one singlet was 
appeared downfield at δ 5.83 [132]. Other signals of the compound in 13CNMR spectrum 
were highly shielded and appeared at δ 12.49-50.0 and one signal in the downfield region 
at δ172.3. The 1HNMR and 13CNMR of the isolated compound were in accordance with 
literature [133] which confirms that the isolated compound was artemisinin (10).  
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Table 4.17 AChE inhibition activity of Artemisinin  (10) 
 
Sr. No. Concentration 
(μg/ml) 
% age Inhibition 
01 50 13.4±0.16 
02 100 19.6±0.27 
03 150 30.1±0.29 
04 200 48.6±0.41 
05 250 52.3±0.38 
 
 
 
Fig. 4.20  AChE inhibition activity of the Artemisinin (10) 
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4.7.2 Kinetic Study of Artemisinin(10) 
 
 
Fig. 4.21 Lineweaver–Burk plot of reciprocal of initial velocities vs reciprocal 
of fixed substrate concentrations in absence (-▲-) and presence of 2.5 
x 103 µM (-▲-), 5x 103 µM (-■-), 7.5x 103 µM (-■-), 10x103 µM (-●-)  
and 15x103 µM (-○-) of  artemisinin (10). 
 
The results of artemisinin showed mix type inhibition against AChE with Ki values   -
736, -668, -633, 646, -502  for2.5x 103, 5.0 x 103, 7.5 x 103, 10.0 x 103, 15.0 x 103 µM 
substrate concentration respectively.  
4.8 Structure Activity Relationship of the isolated Compounds 
During the course of studies AChE inhibitors from plants were purified and 
characterized. Initially the crude extract of the plants based on their traditional use as 
herbal remedy in the folk medicine were screened against acetylcholine esterase. The 
details of the extraction procedure and bioassays are given in the experimental section.  
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Total 10 compounds were isolated from the selected plants and after their structure 
elucidation through spectroscopic techniques i.e UV, IR, EIMS, 1HNMR and 13CNMR, 
etc. These isolated compounds were tested for AChE inhibition potential in a range of 50-
250 μg/ml using Ellman’s method.  
Scopolamine (1) is a tropane alkaloid isolated from D. innoxia. and screened for AChE 
inhibition activity in the range of 50-250 μg/mL concentration. The compound showed 
concentration dependent AChE inhibition. The N-CH3 and epoxy bond in the tropane 
ring plays vital role in the bioactivities and supposed to play key role in inhibition of 
acetyl cholinesterase through binding at the peripheral site of the AChE .The compound 
showed significant AChE activity due to the presence of ‘N’, -OH and epoxy radical 
present in the molecule [92].   
The hesperidin (3) and hesperetin (2) consist of flavonoid skeleton. Sugar molecule is 
attached in the hesperidin molecule which enhances the potential of the molecule against 
AChE inhibition may be due to the presence of –OH group in the sugar molecule. The 
hesperetin contain three –OH group at C-8, C-10 and C-13 along with a methoxy group at 
C-14. As a result it showed good AChE inhibition potential even at low concentration of 
50 μg/mL.  The tendency of hesperetin to inhibit the AChE increases till 200 μg/mL in 
AChE inhibition assay and beyond this concentration there was no significant AChE 
inhibition. 
Hesperidin (3) is present abundantly in citrus fruits and play vital role in plant defense 
system while, in human nutrition compound (3) contributes in the integrity of the blood 
vessels [154]. Various preliminary studies of compound (3) revealed its novel 
pharmaceutical properties as it reduced cholesterol [134] and blood pressure[135] in rats. 
Excessive dose of the compound (3) to rats, decreased bone density loss [136]. Other 
animal studies showed tendency of the compound (3) to protect against sepsis [137]. 
Hesperidin (3) has inflammatory and sedative potential possibly acting through opioid or 
adenosine receptors. In vitro studies of hesperidin (3) also showed the ability to penetrate 
the blood brain barrier. Hesperidin isolated from the methanol extract of C. sinensis is a 
flavanone glycoside. The previous studies indicated the novel pharmaceutical properties 
[138-139] and it is reported to be sedative due to possible action with opioid or adenosine 
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receptor [140-141] and was screened against AChE inhibition activity in the range of 50-
250 μg/mL concentration. The compound (3) showed concentration dependent AChE 
inhibition from 10.1±0.14% at 50µg/mL to 59.7±0.26% at 250µg/mL concentration in the 
bioassay. A significant increase in the AChE inhibition potential was observed at 
200µg/mL as compared to the results of hesperetin (2) at the same concentration 
(34.71±0.06%) (table 4.4). These results can be attributed to the presence of sugar units, 
which might play a role in binding mechanism. 
Catechin (4) isolated from A. catechu possesses two benzene rings (A&B) and a 
dihydropyran heterocycle (C-ring) with a hydroxyl group. The A ring is similar to 
resorcinol moiety while, the B ring is similar to catechol moiety [141]. In transcriptomic 
studies catechin exhibited potential to reduce atherosclerotic lesion development in apo 
E-deficient mice [142].  Catechin (4) has stereospecific opposite effects on glycogen 
metabolism in hepatocytes [143]. Compound (4) inhibit intestinal tumor formation in 
mice [4] and inhibit the oxidation of low density lipoproteins. Catechin (4) isolated from 
the ethyl acetate fraction of A. catechu belongs to the flavanol, subclass of flavonoids and 
screened for AChE inhibition activity in the range of 50-250 μg/mL concentration. The 
compound showed mild AChE inhibition from 1.5±0.46 to 8.5±0.24 in the bioassay. The 
results indicated that the –OH group at a saturated system does not participate in the 
binding of inhibitors with the active sites of the enzyme. Furthermore, the carbonyl group 
at C-4, also seems to be involved in the binding of inhibitors with the enzyme, as shown 
by the lower inhibition potential of catechin as compared to hesperetin or hesperidin 
(table 4.4 and 4.5)   It is quite interesting that catechin (4) is a polyphenol antioxidant and 
also shows good anticarcinogenic activity. 
Gallic acid (5) is present in gallnuts, sumac, witch hazel, tea leaves, oak bark and other 
plants. Compound (5) commonly used in the pharmaceutical industry[174] as a standard 
for determining the phenolic contents of various analytes by Folin-Ciocalteau in which 
results are reported as gallic acid equivalents . It can also be used as a starting material in 
the synthesis of psychedelic alkaloids mescaline [144].  Compound (5) acts as an 
antioxidant and helps to protect our cells against oxidative damage and exhibit 
cytotoxicity against cancer cells, without harming healthy cells. Gallic acid (5) is used as 
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a remote astringent in cases of internal haemorrhage. Compound (5) is also used in the 
treatment of albuminuria and diabetes. Some ointments to treat psoriasis and external 
haemorrhoids contain this compound [145]. From the results in this study it is indicated 
that –OH group present at meta and para position renders the activity of AChE but 
however, the gallic acid molecule show good AChE inhibition.   
Tannic acid (6) used in the treatment of many toxic substances e.g. strychine, mushroom 
and ptomaine poisoning in the late 19th and early 20th centuries [146]. In 1920’s 
introduction of the tannic acid (6) as a healing agent in severe burn injuries helped to 
reduce the mortality rates  and later in world war II tannic acid dressings were prescribed 
to treat burns whether it caused by incendiary bombs, mustard gas or lewisite [147]. Now 
a day’s compound (6) still used in pharmaceutical application in the production of 
albumin tannate which is used as anti-diarrhea agent. Tannic acid was isolated from the 
methanol fraction of A. catechu and screened for AChE inhibition activity in the range of 
50-250 μg/mL concentration. The compound showed mild to moderate AChE inhibition 
from 12.4±0.31 to 43.2±0.58 in the bioassay. The presence of -OH phenolic group in its 
structure supposed to play significant role in the AChE inhibition in this study.   
N-T Gobley in 1858 first time isolated vanillin (7) [148]. Largest use of the compound 
(7) is flavoring, mostly in sweet foods e.g. ice cream, chocolate, confections and baked 
goods. Vanillin (7) also used in perfumes, and to mask unpleasant odors or taste in 
medicines, live stock fodder and cleaning products. The compound (7) is also used as a 
chemical intermediate in the production of pharmaceutical and other chemicals [149]. 
Vanillin isolated from the ethyl acetate extract of Melia azedarach and screened for 
AChE inhibition activity in the range of 50-250 μg/mL concentration. The compound (7) 
showed AChE inhibition from 10.5±0.18 to 50.4±0.17 in the bioassay. The vanillin 
structure is similar with ferulic acid in its skeleton with the difference at –COOH in case 
of vanillin while-CH=CH-COOH in case of ferulic acid at the benzene ring.   
Ferulic acid (8), along with dihydroferulic acid, is a component of lignocellulose, serving 
to crosslink the lignin and polysaccharides, thereby conferring rigidity to the cell walls 
[150]. The compound (8), like many phenols, is an antioxidant due to the reason that it is 
reactive towards free radicals such as reactive oxygen species (ROS). ROS and free 
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radicals are implicated in DNA damage, cancer, accelerated cell aging. Animal studies 
and in vitro studies suggest that ferulic acid (8) may have direct antitumor activity against 
breast cancer  and liver cancer [151]. The compound 8 may have pro-apoptotic effects in 
cancer cells, thereby leading to their destruction [151] and may be effective at preventing 
cancer induced by exposure to the carcinogenic compounds benzopyrene  and 4-
nitroquinoline 1-oxide [152]. If added to a topical preparation of ascorbic acid and 
vitamin E, ferulic acid (8) may reduce oxidative stress and formation of thymine dimers 
in skin [190]. The results of AChE inhibition activity of ferulic acid showed AChE 
inhibition in the  range of 50- 250 μg/mL from  12.38±0.17 to 44.28±0.36 (table 4.13) in 
the bioassays. Ferulic acid (8) is used in the food industry to inhibit oxidation of fats. It is 
also used as starting material for microbial conversion to vanillin. It shows antineoplastic 
properties and gyrostatic activity. Choleretic agent and antifungal agent used to prevent 
fruit spoilage [153]. 
Cinnamic acid (10) is a key intermediate in shikimate and phenylpropanoid pathways. 
Shikimic acid is a precursor of many alkaloids, aromatic amino acids, and indole 
derivatives [154]. Phenylpropanoids are a class of plant metabolites based on 
phenylalanine. They are widely distributed in plants fulfilling many functions including 
plant defense mechanism, pigmentation and external signaling system. Cinnamic acid and 
its derivatives, including esters and carboxylic acid derivatives are used as important 
components in flavours, perfumes, synthetic indigo and pharmaceuticals. Cinnamate can 
also act as optical filters or deactivate substrate molecules that have been excited by light 
for the protection polymers and organic substances [155]. The results of inhibition 
showed AChE by cinnamic acid increases from the 2.6± 0.17 to 19.7±0.19 (table 4.15) in 
the range of 50- 250 μg/mL. The decrease in AChE inhibition activity may be due to 
absence of -OH at para position and -OCH3 at meta position of the benzene ring as in the 
case of ferulic acid. Therefore cinnamic acid showed no significant results in AChE 
inhibition.  
If  we closely look at the structure of the gallic acid (5), tannic acid(6), vanillin (7), 
ferulic acid (8) and cinnamic acid (9) then it is cleared that the basic skeleton of all these 
six compounds based on the benzene ring with substitution through –OH , -COOH,  –
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OCH3 and –C=C-COOH groups at different positions. Yet they are isolated from 
different plants. The ferulic acid (8) and vanillin (7) are similar in the substitution at meta 
and para position of the benzene ring and differ at C-1 position. The results of the AChE 
inhibition potential of compounds (5-8) were found to be correlated with  their structures. 
From the results it is clear that –OH at para position and methoxy group (-OCH3) at meta 
position of the benzene ring enhances the inhibition potential that is  justified with the 
comparison of these compounds AChE inhibition potential results as shown in table 4.18. 
 
Table 4.18:  AChE inhibitory activity of Compounds (5-9)  
 
Sr. 
No. 
Compound 50 μg/mL 100 
μg/mL  
150 
μg/mL 
200 
μg/mL 
250 μg/mL 
01 Gallic acid (5) 12.4± 0.08 19.8± 0.15 22.8± 0.29 29.9± 0.38 36.08± 0.21 
02 Tannic acid(6) 12.4±0.31 23.7±0.28 33.9±0.19 40.7±0.39 43.2±0.58 
03 Vanillin (7) 10.5±0.18 21.3±0.24 34.5±0.53 46.7±0.37 50.4±0.17 
04 Ferulic acid(8) 12.4±0.17 23.8±0.29 33.2±0.09 42.9±0.25 44.3±0.36 
05 Cinnamic 
acid(9) 
2.6± 0.17 6.8±0.21 11.4± 0.14 14.9±0.38 19.7±0.19 
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Fig. 4.22 Graphical presentaion of AChE potential of Compound (5-10). 
From the figure it is evident that compound (8) is the most active at low concentration i.e 
50 μg/mL while the AChE inhibition potential of compound (7) is increasing with the 
increase in concentration and it become maximum at  250 μg/ml might be due to 
aldehyde group while carboxylic group is present in compound (8). In case of compound 
(9) which lack –OH group at para position and –OCH3 at meta position had no significant 
AChE inhibition. From the results compound (9) it is also concluded that –COOH group 
also involve mild inhibition potential of AChE. 
 Artemisinin (10) was first purified in the 1970s. Its structure was determined by a group 
of Chinese scientists to be 3,6,9-trimethyl-octahydro-3,12-epoxy-pyranol[4,3-j]-1,2-
benzodioxepin-10-one by X-ray diffraction analysis. It has a unique structure and lacks a 
nitrogen-containing heterocyclic ring, which is common in most anti-malarial drugs 
[155]. Through numerous studies of its chemistry, pharmacology, toxicology and in 
clinics, artemisinin was proven to be highly effective in treating malaria, including multi-
drug resistant (MDR) strains. The isolation and characterization of artemisinin from A. 
annua L. was considered one of the most important discoveries in contemporary herbal 
research [156]. 
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Fig. 4.23 Graphical presentaion of AChE potential of Compound (1-10). 
 
Although artemisinin has good efficacy against malaria, with properties such as low 
toxicity and rapid onset, there exist two major shortcomings: insolubility in water and oil, 
and poor oral bioavailability, resulting in difficulties with formulation. In order to 
overcome these shortcomings, in vivo metabolic and structural modification studies were 
carried out. All the metabolites isolated from urine had no anti-malaria activity due to the 
loss of an endoperoxide bridge. This suggests that the Endoperoxide Bridge is the active 
group responsible for its biological activity [157]  
Compound (10) was isolated from the ethyl acetate extract of the A. vulgaris and 
screened for AChE inhibition activity in the range of 50-250 μg/mL concentration. The 
compound showed mild to moderate AChE inhibition from 12.4±0.43 to 54.3±0.18 in the 
bioassay. The pharmacology of artemisinin was previously discussed under multi drug 
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resistant strain of falciparum malaria [199]. Therefore, the AChE inhibition potential 
must draw the attention towards its mechanism of action with respect to AChE inhibition.  
Structure-activity studies suggest that the cyclic compounds penetrate the aromatic gorge 
through their ring may be due its more hydrophobic character, or due to increased electro 
positivity of the substituent on the ring []. For the compounds investigated in our study, 
the nitrogen substituent at C-3 and –OH group at para position along with methoxy (-
OCH3) group at adjacent position (meta) were again considered important structural 
features associated with the inhibitory potency, as when protonated at physiological pH 
they may bind similarly to the quaternary nitrogen of known AChE inhibitors[51]. It is 
suggested that stabilization of the AChE-inhibitor complex in the alkaloids may be 
assisted by the amino groups of the inhibitor forming cation-π interactions with the 
Trp279, Tyr70 and Tyr121 residues of the peripheral site of AChE as reported in the 
literature [52]. 
The  crystals of enzyme inhibitor complexes may be grown in future for their molecular 
docking studies to confirm their interaction with AChE. 
